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Abstract  1 
Abstract 
 
Compounds from the marine environment exhibit a wide variety of biological activities, 
and thus hold much promise as potential drugs.  The halichondrins, isolated from the 
Kaikoura sponge Lissodendoryx sp. are no exception to this, demonstrating potent 
anticancer activity.  Novel cytotoxic compounds have also been isolated from the 
Chatham Rise sponge Lamellomorpha strongylata.  Knowledge of the cellular origins 
of such compounds is desirable, in order to establish if the sponge or associated micro-
organisms are producing the compounds of interest.  Siderophores are also important 
molecules, which are produced on demand by bacteria in order to obtain sufficient iron 
necessary for their growth.  Knowledge of the biosynthesis of these compounds has 
potential for the control of undesirable bacteria, such as the anthrax-causing pathogen 
Bacillus anthracis. 
Cell separation studies have been carried out on Lamellomorpha strongylata, locating a 
swinholide in sponge-associated filamentous bacteria and theonellapeptolides in 
sponge-associated unicellular bacteria.  A microscopic analysis of dissociated cells from 
Lissodendoryx sp. was also undertaken. 
The structures of four new halichondrins (3.13 – 3.16), isolated from Lissodendoryx sp., 
have been determined from spectral data.  All of these compounds are very similar to 
known B series halichondrins, with differences occurring only beyond carbon 44.  As 
biological activity has been shown to be derived from the portion of the molecule 
between carbons 1 and 35, they all retain good activity in the P388 assay as expected. 
A new siderophore, petrobactin sulfonate (4.2), was characterised, along with three 
cyclic imide siderophore derivatives (4.3 – 4.5).  Petrobactin sulfonate is the first marine 
siderophore containing a sulfonated 3,4-dihydroxy aromatic ring.  The structures were 
elucidated from spectral data, resulting in a revision of the NMR assignments of 
petrobactin. 
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Abbreviations 
 
br  broad (spectral) 
°C  degrees Celsius 
calcd  calculated 
CIGAR constant time inverse-detection gradient accordion rescaled (NMR) 
cm  centimetre(s) 
CMF-ASW calcium magnesium free artificial seawater 
conc  concentration 
COSY  correlation spectroscopy (NMR) 
d  chemical shift in parts per million downfield from TMS (NMR) 
d  doublet (NMR) 
dd  doublet of doublets (NMR) 
DMSO  dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
ESIMS electrospray ionisation mass spectrometry 
FAB  fast atom bombardment (in mass spectrometry) 
g  gradient (NMR); gram(s) 
GTP  guanosine 5'-triphosphate 
GDP  guanosine 5'-diphosphate 
H2O  water 
HMBC heteronuclear multiple bond correlation (NMR) 
HPLC  high-performance liquid chromatography 
HRFABMS high-resolution fast atom bombardment mass spectrometry 
HSQC  heteronuclear single quantum correlation (NMR) 
Hz  hertz 
J  coupling constant (NMR) 
kDa  kilo Daltons 
L  litre(s) 
LCMS  liquid chromotography mass spectrometry 
LCMSMS tandem liquid chromotography mass spectrometry 
LRFABMS low resolution fast atom bombardment mass spectrometry 
m  micro 
m  multiplet (spectral); milli 
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M  moles per litre 
mmu  milli mass units 
MAPs  microtubule associated proteins 
MDR  multidrug resistance 
MeOH  methanol 
mol  mole(s) 
MS  mass spectrometry 
MTOC  microtubule organising centres 
m/z  mass to charge ratio (in mass spectrometry) 
n  nano 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect (NMR) 
NOESY nuclear Overhauser effect spectroscopy (NMR) 
NSCLC non small cell lung cancer 
ODS  octadecyl silane 
P-gp  p-glycoprotein 
ppm  parts per million (NMR) 
rt  room temperature 
ROESY rotating-frame NOE spectroscopy (NMR) 
RP-HPLC reverse phase high performance liquid chromatography 
s  singlet (NMR); second(s) 
SEM  scanning electron microscopy 
t  triplet (NMR) 
TEM  transmission electron microscopy 
TFA  trifluoroacetic acid 
TLC  thin layer chromatography 
TMS  tetramethylsilane 
TOCSY total correlation spectroscopy (NMR) 
UV  ultraviolet
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CHAPTER 1.  Introduction. 
1.1  General introduction 
The marine environment represents a huge, and still largely untapped, resource for the 
discovery of novel natural products due to its vast biological diversity.  Although 
having around one fifth the average biomass of terrestrial habitats, it is conservatively 
estimated that between 0.5 and 10 million of the world's total estimated 12.5 to 30 
million species are accounted for by marine macrofauna alone.1  In addition, although 
biomass decreases exponentially with depth, species diversity has been shown to 
increase.1  Thus, a strong case can be made for the search for novel compounds in 
species from deep marine habitats.  Thousands of secondary metabolites (compounds 
not involved in primary metabolism) have been isolated to date from marine organisms, 
often with unprecedented structures.  Many of these are derived from sessile organisms, 
such as sponges, ascidians and soft corals, and arguably act as chemical defences to 
deter predators or discourage epibiosis.2,3 
The need for new drugs is constantly growing.  Diseases such as Alzheimer’s and 
arthritis continue to deny those affected quality of life, heart disease is prevalent, 
absolute cures for cancer and AIDS have not been found, drug-resistant strains of 
bacteria have evolved, cancers have developed multi-drug resistance, and the threat of 
bioterrorism is an increasing concern.  The use of marine-derived secondary metabolites 
in these applications has been explored with much success.  Within the Marine 
Chemistry Group at the University of Canterbury, of the thousands of marine organisms 
collected, extracted and screened in the group's in-house assays for antitumour, antiviral 
and antimicrobial activity, many with promising activity have been identified.  These 
include the halichondrins from the Kaikoura deep water sponge Lissodendoryx sp. and a 
variety of novel compounds isolated from the Chatham Rise sponge Lamellomorpha 
strongylata.  Terrain models of the Kaikoura and Chatham Rise areas are given in 
Figures 1.1.2 and 1.1.2, respectively. 
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Figure 1.1.1  Oblique terrain model showing the underwater topography surrounding the Kaikoura 
Peninsula.  The blue arrow indicates the collection site of Lissodendoryx sp..  Image courtesy of NIWA. 
Figure 1.1.2  Terrain model showing the underwater topography surrounding New Zealand.  The arrow 
indicates the collection site of Lamellomorpha strongylata on the Mernoo bank, Chatham Rise.  Image 
courtesy of NIWA. 
 
The use of marine natural products dates back to pre-Roman times with the utilisation of 
precursors from a mucus secretion of the hypobranchial gland of marine snails of the 
genus Murex (Fig. 1.1.3) to obtain the highly prized pigment Tyrian purple, the main 
component of which is 6,6′-dibromoindigo (1.1).4  While the study of natural products 
has been a major focus of the discipline of chemistry for over a century, most of the 
effort has been on natural products derived from terrestrial sources.  This emphasis 
began to change after the 1950s when the impact and significance of Werner 
Bergmann’s pioneering work on natural products from the marine environment was 
recognised.  Bergmann started his work on marine natural products in 1933, and 
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published the 50th article in his “Marine Product” series in 1961.  The work for which 
he is widely recognised was the isolation and characterisation in the early 1950s of the 
non-ribose nucleosides, spongothymidine (1.2) and spongouridine (1.3), from the 
Caribbean sponge Tethya crypta.  Within a decade of these discoveries, the biomedical 
importance of non-ribose nucleosides was being realised, and the development of drugs 
such as Ara-C, Ara-A and AZT (1.4) can be traced directly back to Bergmann’s work. 
 
Figure 1.1.3  Two of the source organisms of the precursors for the pigment Tyrian purple, Murex 
brandaris and M. trunculus.  (Image: www.dutly.ch/indigohtml) 
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The delayed onset of more extensive research into marine natural products was partly a 
consequence of the relatively limited access that biologists and chemists had to that part 
of the marine environment beyond the sub-tidal zones.  This was remedied by the 
popularisation of SCUBA that dramatically enhanced the ability to collect in the aquatic 
environment, as well as opening up possibilities for marine environmental chemistry.  
SCUBA was followed in turn by the use of ROVs and various submersibles that have 
allowed access to very much deeper water.  Along with the enhanced collecting 
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opportunities came the recognition that most of the biodiversity on earth was actually 
present in the oceans. 
From the recognition of the importance of marine natural products in the 1950s the field 
progressed steadily with the next champion being Paul Scheuer, sometimes referred to 
as the father of marine natural products, who began his work at the University of Hawaii 
at Manoa in 1950.  Joining Scheuer as leaders in the field were Ken Rinehart, working 
at the University of Illinois from 1954, and John Faulkner, working at Scripps 
Institution of Oceanography, UCSD, from 1968.  Sadly, all three are recently deceased, 
but they have left an extensive legacy from their work in the field of marine natural 
products.  Paul Scheuer published around 300 papers, including a report of the new 
anticancer compound kahalalide F (1.5) from the Sacoglossan mollusc Elysia rufescens 
and the green alga Bryopsis sp.,5,6 which is not susceptible to multidrug resistance 
(MDR) mechanisms (vide infra) and is currently in clinical trials, predominantly for the 
treatment of prostate cancers.7  Ken Rinehart published over 400 papers, including the 
isolation of didemnin B (1.6),8 an anticancer and antiviral agent from the ascidian 
Trididemnum solidum, which was the first marine natural product to enter clinical trials.  
John Faulkner published over 350 papers in the areas of natural product chemistry and 
chemical ecology, including the discovery of over 100 halogenated compounds.  His 
work on the anti-inflammatory terpenoid manoalide (1.7), first isolated by Scheuer from 
the Western Pacific sponge Luffariella variabilis,9 led to the discovery of a new class of 
anti-inflammatory compounds,10-12 and his work on opisthobranchs (shell-less molluscs) 
led to the theory that their co-existence with toxic food sources resulted in the evolution 
of their shell-less state. 
Further development of the studies on marine natural products from the 1970s onwards 
was assisted by advances in spectroscopic methods and separation science that allowed 
for the rapid isolation and characterisation of the many new structural types being found 
from the sea.  Since then, the number of groups undertaking research in the area has 
grown rapidly, as reflected by the rapid increase in marine natural product publications, 
and the establishment of marine natural products as a separate focal point at 
conferences.  Currently, the studies on marine natural products are carried out by a wide 
range of research groups (in excess of 150) scattered across at least 40 countries.  
Research in the marine natural products area is characterised by a sense of unity, with 
many of the current leaders of the field being able to trace an academic ancestry back to 
having worked for, or with, Scheuer, Rinehart or Faulkner.13 
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The marine environment has yielded many compounds with potent biological activity.  
The analgesic ziconotide (PrialtÒ), a 25-residue peptide from the marine snail Conus 
magus, has recently been approved for use as an analgesic and is the first marine natural 
product to reach the commercial sector.  Ecteinascidin 743 (1.8), an antimitotic 
anticancer agent from the ascidian Ecteinascida turbinata first reported in consecutive 
papers by Rinehart et al. and Wright et al.,14,15 is predicted to follow later this year.  In 
addition, there are currently a significant number of very interesting marine natural 
products, or their synthetic derivatives, that are in clinical or preclinical trials for the 
treatment of cancer, analgesia, allergy and cognitive diseases.7 
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1.2  Sponges 
Sponges are sessile marine organisms, classified in the phylum Porifera (meaning 
“pore-bearing”).  There are over 9000 species known, mostly marine, in habitats 
ranging from the intertidal zone to deeper than 8500 m.16  They range in size from a few 
millimetres to two metres high.  The body of a sponge has an outer and an inner layer 
separated by an acellular gel layer, the mesohyl.  The outer layer is comprised of a 
tightly packed layer of pinacocytes.  In the gel layer are spicules (supportive needles 
made of calcium carbonate or silica that are secreted by sclerocytes) and/or spongin 
fibres (a flexible skeletal material made from protein that is secreted by spongocytes), 
along with spherulous cells (cells with multiple large vesicles containing course 
granular material).  The inner layer of the sponge is made up of flagellated cells called 
choanocytes. 
Adult sponges are filter-feeders.  Water is drawn into the organism through incurrent 
pores surrounded by myocytes and porocytes, which can contract to regulate the flow 
through the sponge.  The water then passes the flagellated choanocytes that line the 
inside of the sponge.  The beating flagella propel water through the sponge, while 
nutrients are absorbed via the collars of the choanocytes.  Archeocytes subsequently 
transport the nutrients from the choanocyte collars to other cells in the sponge.  The 
water then exits the sponge through the osculum, which is often lined with spicules.  
Spicules may also penetrate the outer layer of the sponge (Fig. 1.2.1) 
 
Figure 1.2.1  A diagram of a sponge, showing choanocytes (A), pinacocytes (B), incurrent pores (C), the 
osculum (D), archeocytes (E) and spicules (F).  (Image: www.biologycorner.com) 
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Sponges 38%
Coelenterates 21%
Molluscs 7%
Tunicates 7%
Echinoderms 3%
Microorganisms & 
Phytoplankton 
15%
Green algae 1%
Red algae 6%
Brown algae 2%
Spicules are found in many shapes and sizes (large spicules are called megascleres, and 
small ones microscleres) and have structural and defence functions. Their diversity has 
proven useful in the classification of sponges. 
Sponges are a rich source of new marine natural products, many of which are bioactive.  
Of all the new compounds reported by the end of 2001, 38 % were obtained from 
sponges (Fig. 1.2.1). 
Figure 1.2.1  Distribution of marine natural products by phylum, 200117 
 
1.3  Compounds derived from Lamellomorpha strongylata 
In 1997, four classes of compound were isolated from the marine sponge 
Lamellomorpha strongylata, collected by benthic dredging in deep water (80-100 m) 
along the top of the Mernoo Bank within the Chatham Rise convergence zone off the 
east coast of the South Island of New Zealand.  Compounds isolated were from the 
calyculin, calyculinamide, swinholide and theonellapeptolide classes.18,19 
1.3.1  Calyculins and calyculinamides 
The anticancer compound calyculin A was first reported by Fusetani in 1986, isolated 
from the sponge Discodermia calyx.20  Two years later, Fusetani reported the structures 
of calyculins B, C and D from the same sponge,21 and other calyculins have been 
described subsequently.  The known calyculins A, B, E and F were isolated from 
Lamellomorpha strongylata.  In addition, two new calyculin derivatives, 
calyculinamides A and B, were isolated from this sponge.  These structures are given in 
Chapter 2 (2.1 - 2.6). 
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1.3.2  Swinholides 
The potent cytotoxic macrolide swinholide A was first isolated in Kashman’s group 
from the sponge Theonella swinhoei, collected in the Red Sea.22,23  It has subsequently 
been isolated from an Okinawan population of the same sponge,24 when it was 
recognised as a dimer, and more recently still from sponge-associated heterotrophic 
bacteria25 and marine cyanobacteria collected in Fiji.26  The new swinholide H was 
isolated from Lamellomorpha strongylata.  Swinholide I was reported in 2006.27  The 
structure of swinholide H is given in Chapter 2 (2.7). 
1.3.3  Theonellapeptolides 
A variety of theonellapeptolides have been reported by Kitagawa et al. from an 
Okinawan sponge of the genus Theonella.28-31  Theonellapeptolide IIIe was isolated 
from Lamellomorpha strongylata, and showed modest cytotoxicity (7.4 mg/mL) against 
the P-388 cell line.  The structure of theonellapeptolide IIIe is given in Chapter 2 (2.8). 
 
1.4  Halichondrins 
The halichondrins, potent antitumour polyether macrolides, were first isolated by 
Uemura et al. from the Japanese sponge Halichondria okadai.  The structure of 
norhalichondrin A (3.1) was determined by NMR and X-ray crystallography and 
reported in 1985.32  The following year, Uemura reported the structures of seven further 
halichondrins from the same sponge, the most active of which was halichondrin B 
(1.9).33  The structures of ten halichondrins from the B series were reported in 1991 by 
the Marine Group at the University of Canterbury from the New Zealand sponge 
Lissodendoryx sp. (see chapter 3), and halichondrins have also been isolated from 
various other sponges, including the halistatins from the east Indian sponge Phakellia 
carteri,34 and halichondrin B and homohalichondrin B from Axinella sp., collected in 
Palau.35  The halichondrins are characterised by a large 22-membered lactone ring (C1-
C30), two exocyclic methylenes, at C19 and C26, an unusual tricyclo ring system (C8-
C14) and a number of pyranose and furanose rings. 
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As is the case for other marine natural products, the halichondrins occur at very low 
levels in the sponge.  Lissodendoryx sp. is the highest yielding sponge, producing 
approximately 1.6 mg of total halichondrins per kilogram of wet sponge.33-35  In an 
attempt to address the supply problem, several groups have attempted the synthesis of 
halichondrin B.  The total synthesis of halichondrin B and norhalichondrin B was 
reported by Kishi in 1991.36  Unfortunately, it involves close to 50 steps in the longest 
linear sequence, rendering it unsuitable for the commercial supply of the halichondrins.  
This is the only total synthesis reported to date, however Kishi’s group at Harvard 
University, along with other synthetic groups including that of Steven Burke at the 
University of Wisconsin-Madison and Andrew Phillips at the University of Colorado at 
Boulder, continue to attempt the synthesis of halichondrin B in fewer steps and with 
higher yields.  The recent discovery that the truncated halichondrin B analogue NSC 
707389 (3.12)37 retains the activity of the parent compound38 can only serve to increase 
the likelihood of the development of a commercially viable synthesis. 
The halichondrins are cytotoxic at subnanomolar concentrations, preventing tubulin 
polymerisation and microtubule assembly by inhibiting the binding of GTP to tubulin.39 
They have also been shown to interfere with the binding of the vinca alkaloids to 
tubulin, binding in the vinca domain,40 and induce apoptosis via a mitotic prophase 
stall.41 Again, like kahalalide F (1.5), these compounds have the advantage of not being 
recognised by MDR mechanisms (vide infra).  A recent publication proposes a tubulin 
binding site for halichondrin B and its analogue NSC 707389 between the two 
heterodimers, leading to the formation of highly unstable, small aberrant tubulin 
polymers rather than the massive stable structures observed with the vinca alkaloids.38  
The halichondrins are active against selected sensitive melanoma, colon, ovarian, lung 
and breast cancer cell lines. 
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In order to understand the mode of action of the halichondrins, it is necessary to 
investigate the nature of cancer, chemotherapy and the cell cycle, and understand 
tubulin, the formation of microtubules, and how these microtubules might be disrupted 
by an anticancer agent. 
 
1.5  Cancer 
In western countries, cancer is second only to heart disease as the biggest cause of 
death.42  Cancer is a generic term for over 200 diseases with shared characteristics, 
including uncontrolled cellular proliferation.  Normal cells demonstrate contact 
inhibition, where cell proliferation ceases once cells come into contact with one another.  
In contrast, cancer cells continue to proliferate until all available resources are 
exhausted.  Thus, the fine balance between cell production and cell death is lost, and an 
over production of cells results at the expense of the host tissues.  This proliferation can 
interfere with surrounding organs, disrupting their function, and ultimately lead to the 
death of the patient.  A complicating feature of cancer is its ability to spread to other 
locations in the body, a process known as metastasis.  Thus, secondary tumours are also 
observed to disrupt bodily functions at many different locations.  This renders surgical 
removal of the tumours impractical, and chemotherapy (involving the use of drugs) 
becomes the treatment of choice. 
 
1.6  Chemotherapy 
The ultimate aim for chemotherapy is to specifically target cancer cells whilst leaving 
healthy cells untouched.  In order to achieve this, a unique feature of the cancer cells 
must be exploited.  Unfortunately, the differences between cancer cells and healthy cells 
seem to be very slight.  However, as mentioned previously, cancer cells show an 
increase in cell growth and division.  Thus, it may be possible to target the process of 
segregation of chromosomes prior to cell replication (mitosis) in these cells.  Prolonged 
disruption of the cell cycle has been found to result in apoptosis, or programmed cell 
death.  In other words, if the cell is not viable, it commits suicide.43,44  Although mitosis 
also occurs in healthy cells, it has been demonstrated that it is possible to obtain 
selectivity towards the more frequently dividing cancer cells.  Common side effects 
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associated with chemotherapy, such as hair loss, neutropenia (decrease in neutrophils in 
the blood) and peripheral neuropathy (loss of peripheral nerve function) are a result of 
these types of cells also demonstrating rapid replication.45 
 
1.7  Cell cycle 
The cell cycle is composed of three parts: interphase, mitosis and cytokinesis (Fig. 
1.7.1).  During interphase, the cytoplasmic material doubles in the G1 (gap) phase, the 
chromosomes are replicated in the S (synthesis) phase, and tubulin and other molecules 
necessary for mitosis are synthesised in the G2 phase.  During mitosis, the chromosomes 
are divided between two daughter cells.  Finally, during cytokinesis, the daughter cells 
separate to give two new cells, with actin and myosin microfilaments acting to pinch the 
cells apart. 
                       
      a.               b. 
 
Figure 1.7.1  (a) A digital fluorescence micrograph of an animal cell in the late stages of cytokinesis.  
(Image: www.molecularexpressions.com)  (b)  Fluorescence micrograph of a mammalian cell undergoing 
cytokinesis.  (Image: http://biology-web.nmsu.edu/shuster-lab) 
1.7.1  Mitosis 
Mitosis occurs in five phases: prophase, prometaphase, metaphase, anaphase and 
telophase.  The mitotic spindle is formed in the first of these phases.  This is comprised 
of four different types of microtubule: astral rays, pole-to-pole microtubules, 
microtubules that bind to kinetochores, and microtubules that interact with chromosome 
arms (Fig. 1.7.2). 
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Figure 1.7.2  The four different types of microtubule: astral rays, pole-to-pole microtubules, microtubules 
that bind to kinetochores, and microtubules that interact with chromosome arms.  (Image: 
www.emc.maricopa.edu) 
Kinetochores are DNA-protein complexes that form on centromers.46  As will be 
discussed below, microtubules attached to the kinetochore lengthen during prophase and 
shorten during anaphase.  This is achieved by the addition or removal of tubulin dimers.  
The tubulin is sourced from cytoskeletal microtubules, which are observed to 
disassemble at the beginning of mitosis and reassemble following the dispersion of the 
mitotic spindle after mitosis has occurred.  This borrowing of cytoskeletal tubulin is also 
thought to be the reason why cells appear rounded during mitosis. 
1.7.2  Prophase 
This is the longest phase, taking ~60% of the total time 
required for mitosis.  During this phase, the chromatin 
condenses so that the individual chromosomes become visible, 
the centrioles move to opposite ends of the cell, and the 
spindle forms.  A fluorescent micrograph of a cell during this 
phase is shown.  (This and subsequent mitosis images: http://valelab.ucsf.edu/research) 
1.7.3  Pro-metaphase 
During this phase, microtubules attach to the centre of the 
chromosomes at a point known as the kinetochore, and the 
nuclear envelope breaks down. 
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1.7.4  Metaphase 
During this phase, chromosomes move to align with the mid 
plane (or equator) between the centrosomes. 
 
 
 
1.7.5  Anaphase 
This is the most rapid phase of mitosis.  As soon as the 
chromosomes are aligned with the equator, the microtubules 
begin to decay, separating the daughter chromosomes. 
 
 
 
1.7.6  Telophase 
During this phase, the chromosomes reach the opposite poles 
of the cell, and new nuclear envelopes form. 
 
1.8  Tubulin 
Tubulin is found in every nucleated cell in the body.  It is comprised of two similar 
spherical proteins, a- and b-tubulin, each with a molecular weight of about 50 kDa.  
The a- and b-tubulin proteins combine to form ab soluble heterodimers.  Two 
molecules of guanosine triphosphate (GTP) bind to each of these heterodimers.  One of 
these is tightly bound and cannot be removed without denaturing the heterodimer, while 
the other is freely exchangeable with unbound GTP.  This exchangeable GTP molecule 
is thought to be crucial for the regulation of tubulin function.47 
The ab-tubulin heterodimers are able to combine in a head to tail arrangement to form a 
protofilament, a long protein fibre composed of alternating a- and b-tubulin.  During 
polymerisation, the exchangeable GTP is hydrolysed to guanosine diphosphate (GDP).  
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The non-exchangeable guanosine nucleotide appears to be on a-tubulin, while the 
exchangeable nucleoside has been localised to the b-tubulin subunit.48 
1.8.1  ab-Tubulin heterodimer 
The structure of the ab-tubulin heterodimer was determined via electron 
crystallography by Eva Nogales, Sharon Wolf and Kenneth Downing from the 
Lawrence Berkeley National Laboratory, and reported in Nature in 1998.49,50  This 
confirmed the location of the non-exchangeable guanosine nucleotide sites on a- and b-
tubulin, respectively.  An example of the amino acid sequences of pig brain a- and b-
tubulin is given in Fig. 1.8.1. 
 
Figure 1.8.1  Amino acid sequences of pig brain a- and b-tubulin.  Strands are shown as blue arrows, and 
helices are denoted in red.49 
 
The a- and b-tubulins were found to share 40% amino-acid sequence identity, whilst 
existing in several isotype forms.  Six a- and six b-tubulin isotypes have been described 
in mammals.51  The structures of a- and b-tubulin were found to be basically identical, 
with each monomer being formed by a core of two b-sheets surrounded by a-helices 
(Fig. 1.8.2). 
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Figure 1.8.2  Ribbon diagram of the ab-tubulin heterodimer, with the a-subunit on top and the b-subunit 
underneath.  Strands are denoted with green arrows, and helices by blue and yellow spirals.  GTP (pink 
molecule) in the non-exchangeable (top) and exchangeable (bottom) sites is also shown.49 
1.8.2  Microtubules 
Microtubules are dynamic pipe-like fibres.  They are insoluble, and have a variety of 
roles in the cell, including the provision of an internal scaffold, cellular transport, and 
the formation of the mitotic spindle.  Microtubule assembly occurs via the grouping 
together of protofilaments (typically 12 or 13) to form a C-shaped protein sheet.  This 
sheet then curls to form a microtubule, where the external diameter is ~24 nm and the 
internal bore is ~15 nm. 
The dynamic nature of the microtubules is crucial to their function.  They are in 
constant equilibrium, with dimers continually adding to and leaving from each end.  
This process is a finely balanced equilibrium, with net addition from the positive (+) 
end of the microtubule (capped by b-tubulin) and net loss from the negative (-) end 
(capped by a-tubulin).  This length control of the microtubule is vital for its intracellular 
function.  The microtubule is said to be treadmilling when it is simultaneously gaining 
dimers at one end and losing them from the other (Fig. 1.8.3).  This phenomenon is 
believed to be critical for the polar movement of chromosomes during anaphase (vide 
infra).51 
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Figure 1.8.3  A schematic diagram showing the dynamic nature of microtubules, with ab-tubulin 
heterodimers constantly joining and leaving each end.  Net addition occurs at the + end (left hand side), 
and net loss from the – end (right hand side).  a-tubulin is shown in blue, and b-tubulin in green.  
(Image: http://python.rice.edu) 
1.8.3  MAPs and MTOCs 
A number of proteins, known as Microtubule Associated Proteins (MAPs), are 
associated with the microtubules.  These have a mass of ~200 kDa, and their exact 
purpose is unknown.  However, microtubules are observed to form faster in their 
presence, and they also appear to provide protection from depolymerisation by Ca2+ 
ions and at low temperatures. 
Microtubule Organising Centres (MTOCs) are crucial in the formation of the 
microtubules.  All microtubules initially begin to grow from one of these centres.  In 
most cells, the major type of MTOC is the cell centre or centrosome, which contains 
two microtubular structures called centrioles. 
1.8.4  g-Tubulin 
g-Tubulin is a third type of tubulin protein.  It is similar to both a- and b-tubulin, and its 
presence is essential for microtubule growth in vivo.  It is thought that an aggregation of 
g-tubulin on the surface of the MTOC, perhaps in the form of a ring or short cylinder, 
acts as a site of nucleation for incoming ab-tubulin heterodimers. 
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1.9  Targeting microtubules 
1.9.1  Rationale 
Microtubules are intimately involved in cell replication.  On entering mitosis, 
microtubule growth/decay increases 20 to 100-fold, thus making them highly sensitive 
to interference.44  If prevention of the formation or decay of the microtubules were 
achieved, this would have the effect of preventing the separation of the chromosomes.  
Thus, the cell would be prevented from reproducing, and in the case of cancerous cells, 
the tumour would not be able to grow.  Such anticancer agents are known as spindle 
poisons.  Of course, as discussed earlier, microtubules have a variety of other roles in 
the cell.  The abundant amount of tubulin in neurons and the role of microtubules in 
axonal transport are thought to contribute to the neurological toxicity of tubulin-binding 
agents in the clinic.51 
1.9.2  Spindle poisons 
Spindle poisons have been described in several classes, determined according to their 
binding site on the ab-tubulin heterodimer.  Although some of these compounds bind to 
sites which are as yet uncharacterised, others are known to bind to: 
 tubulin sulfhydryl groups 
 the colchicine binding site 
 the vinca alkaloid binding site 
 the rhizoxin / maytansine binding site (or the vinca domain) 
Cytochalasin A (1.10) is a fungal metabolite that acts by forming a covalent adduct with 
the sulfhydryl groups of tubulin.  Thus, the alkaloid is able to prevent microtubule 
assembly.  Interestingly, its binding has also been shown to block the colchicine binding 
site.42 
Colchicine (1.11) was originally purified early in the 19th century from the meadow 
saffron Colchicum autumnale, and has long been associated with its binding to tubulin, 
once being known as the “colchicine binding protein”.  It is a highly toxic and highly 
soluble alkaloid that has a long history as a treatment for gout, a treatment that remains 
today, along with that of familial Mediterranean fever and cirrhosis of the liver.  It is 
also being investigated as a treatment for primary Sclerosimy cholangitis, a liver 
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disease.52  It exhibits temperature-dependent strong binding to the ab-tubulin 
heterodimer, and thus hinders microtubule assembly.53 
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The vinca alkaloid binding site is that defined by the binding of the vinca alkaloids 
vinblastine (1.12) and vincristine (1.13) on the ab-tubulin heterodimer.  It has been 
localised to the central region of b-tubulin,54 preventing the binding of b-tubulin GTP.  
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microtubule polymer, further microtubule growth is prevented.  Thus, endwise 
poisoning blocks the region involved in heterodimer attachment, halting the 
polymerisation process and suppressing the dynamic instability of microtubules 
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The vinca domain is a distinct site which appears to lie between the vinca site and the 
exchangeable GTP site.  Vinca domain binders may affect these other sites through a 
slight overlap.  Again, the binding of these agents prevents the formation of the mitotic 
spindle.  Agents which act at this site include rhizoxin (1.14) from the fungus Rhizopus 
chinensis, maytansine (1.15) from the plants Maytensus sp. and Putterlickia 
verrucosa,48 and the marine sponge-derived halichondrins, for example halichondrin B 
(1.9). 
Another well known antimitotic drug is Taxol® (1.16), also known as paclitaxel, 
isolated from the bark of the western yew tree Taxus brevifolia55 along with other 
members of the Taxus family, and also from a culture of a fungus, Taxomyces adreanae, 
found growing on T. brevifolia.56  Interest in the compound increased dramatically eight 
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years after it was first reported, when it was discovered that it acts by stabilising 
microtubules, thus preventing their depolymerisation, rather than destabilising them as 
was the case for all the other antimitotic compounds then known.57  It also causes a 
prolonged blockage at metaphase in the cell cycle, thus triggering apoptosis 
(programmed cell death). Taxol® is now used clinically in the treatment of ovarian and 
breast cancer.43  However, due to its low water solubility, delivery is achieved in an oil 
(Cremophor), which can cause cardiac and allergy problems at high doses.  Treatment 
with Taxol® cannot be combined with radiotherapy as it acts by blocking the cell cycle 
between G2 and mitosis in both tumour and non-tumour cells, and healthy cells have 
been shown to be more sensitive to radiation in these phases of the cell cycle.45 
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Taxotere (1.17), or docetaxel, discovered as a late stage intermediate in a Taxol® 
synthetic strategy, has a similar mode of action to Taxol® but with a four-fold increase 
in potency and improved water solubility.  It is produced semi-synthetically from a 
precursor readily obtained from yew tree needles, thus ameliorating the supply problem, 
and clinical trials are in progress.43  Binding of taxotere to the ab-tubulin heterodimer 
has been investigated via electron crystallography (Fig. 1.9.1), indicating that binding 
occurs on b-tubulin in an intermediate domain between the amino-terminal and 
carboxy-terminal domains.49 
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Figure 1.9.1  Ribbon diagram of the ab-tubulin heterodimer determined by electron crystallography, with 
the a-subunit on top and the b-subunit underneath, showing the binding of taxotere (yellow molecule) in 
an intermediate domain of b-tubulin.  Strands are denoted with green arrows, helices by blue spirals and 
GTP is in pink.49 
 
1.10  Multidrug resistance 
The phenomenon of multidrug resistance (MDR) was first reported in the late 1960’s 
and early 1970’s.58  It represents the major cause of cancer treatment failure.  Many 
cancers do not respond to treatment with some antimitotic agents.  In addition to this, 
however, some types of cancers respond initially to treatment with a particular drug, but 
then acquire resistance to it, and also to other drugs that had not previously been used.  
Thus, the tumour acquires resistance to a variety of chemotherapeutic agents following 
the administration of a single agent.45,59  This appears to be due to the over-expression 
of a family of related genes which code for transporters and actively pump the drugs out 
of the cell.60 
1.10.1  Multiple proposed MDR mechanisms 
Multiple mechanisms for multidrug resistance have been investigated.  One such 
mechanism is the formation of mutant b-tubulin, resulting in tumours resistant to 
Taxol®.61  Some resistant cell lines have been shown to contain tubulin alterations, 
encompassing total tubulin content, tubulin polymerisation, or tubulin isotype content.  
For example, the taxane resistant cell line KPTA5 has been shown to have an increased 
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incidence of the class IVa tubulin isotype.51  Other mechanisms include the existence of 
a glutathione conjugate export pump,62 the presence of a multidrug resistance-associated 
protein (MRP) which is a 190 kDa membrane glycoprotein and is an efficient 
transporter of vinca alkaloids but not of taxanes,51 the existence of a lung cancer 
resistance protein (LRP-56) whose presence is not entirely definitive but whose over-
expression is implicated in MDR leukaemia and ovarian cancer,58 and finally, the 
removal of a drug via the P-glycoprotein (P-gp) efflux pump. P-gp is a 170 kDa (1280-
amino acid) transmembrane glycoprotein, expressed on the plasma membrane of tumour 
cells, and is currently the best characterised drug transporter.  It is likely that resistant 
cancers express more than one mechanism of resistance to any particular drug.59 
1.10.2  P-Glycoprotein pump 
P-gp is thought to function as a transmembrane pore-forming protein,58 and is encoded 
by the mdr1 gene.  P-gp is found to be increased or over-expressed in many drug 
resistant cells.  It is expressed both as an acquired mechanism (in the case of 
leukaemias, lymphomas, breast and ovarian carcinomas, where mdr1 is not expressed at 
diagnosis, but appears after relapse from remission) and inherently (in the case of 
colorectal and renal cancers, where mdr1 is highly expressed from the outset).59  Both 
the vinca alkaloids and the taxanes are good substrates for this pump.51 
1.10.3  Combating MDR 
One method used to thwart MDR is to co-administer a compound that will block the 
efflux pump.  These compounds are called chemosensitisers, an example of which is the 
cyclosporin analogue PSC833.  Although PSC833 has been shown to restore the 
sensitivity of previously drug-resistant cell lines to anticancer agents, its use is 
recommended as a matter of course in the clinical administration of drugs known to 
cause MDR, in order to prevent the onset of MDR.63  Another method to combat MDR 
involves the use of a polymer drug conjugate.  It has been found that the use of 
doxorubicin in a polymer drug conjugate decreased the level of MDR usually 
experienced by the free drug against MDR cell lines.  This is due to the fact that cellular 
uptake of the polymer drug conjugate is restricted to the process of endocytosis, due to 
its size, resulting in at least a partial bypass of the P-gp efflux pump that would 
otherwise remove the drug from the cell.  Further, the combination of such conjugates 
with chemosensitisers restored almost completely the sensitivity of these cell lines to 
that of parental lines.64  A much simpler solution for overcoming MDR, however, is to 
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select drugs that are not susceptible to removal by these mechanisms.  One such 
compound is isohomohalichondrin B (3.3). 
 
1.11  Marine siderophores 
Most micro-organisms require iron for growth.  Although iron is one of the most 
abundant elements in the earth’s crust, it is present at very low levels in surface 
seawater.  Under aqueous aerobic conditions, iron is present in the +3 oxidation state 
which renders it highly insoluble.  In addition, over 99% of the dissolved iron is 
complexed by organic ligands.  In order to obtain iron, micro-organisms produce 
siderophores (Greek for iron carrier), high affinity iron chelators which bind iron(III) 
and facilitate its transport into the cell.  Siderophore production has been shown to 
increase under low iron conditions and decrease under high iron concentrations.65  
High-affinity receptor proteins which recognise siderophore – iron(III) complexes and 
transport them into the cell have also been shown to be regulated by iron levels.65 
Although hundreds of siderophores from terrestrial sources have been isolated, 
relatively few marine siderophores have been characterised to date.  Examples from the 
marine environment include aerobactin (1.18), isolated from a Vibrio sp. in Margo 
Haygood’s laboratory,66 petrobactin (1.19), isolated from Marinobacter 
hydrocarbonoclasticus in Alison Butler’s laboratory,67,68 and the sulfonated siderophore 
pseudoalterobactin A (1.20), isolated from a marine Pseudoalteromonas sp. by Kaneo 
Kanoh’s group in Japan.69 
Petrobactin has also been identified as a virulence-associated siderophore produced by 
Bacillus anthracis (the anthrax-causing pathogen) under iron-deficient conditions.70  A 
recent publication has characterised a key enzyme involved in the biosynthesis of 
petrobactin.71  This is an exciting development, as it opens up the possibility of 
targeting the enzyme for the purpose of developing a new anti-infective agent. 
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1.12  Thesis aims 
The research presented in this thesis falls into the following three categories: 
i) Cell separation studies on the New Zealand marine sponges Lamellomorpha 
strongylata, collected in deep water (80-100 m) along the Chatham Rise, and 
Lissodendoryx sp., collected in deep water (~100 m) off the Kaikoura 
Peninsula. 
ii) Characterisation of new halichondrins from the New Zealand marine sponge 
Lissodendoryx sp.. 
iii) Characterisation of siderophores from the oil-degrading marine bacterium 
Marinobacter hydrocarbonoclasticus. 
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CHAPTER 2.  Cell Separation Studies. 
 
2.1  Introduction 
There has been considerable debate over the last decade as to the ecological origin of 
many of the compounds isolated from marine organisms.  Are they synthesised by the 
organism itself or by a symbiont?  Research has shown that cytotoxic components, 
originally isolated from the sponge Theonella swinhoei (Order Lithistida, Family 
Theonellidae), are in fact derived from bacterial symbionts.25  For such a compound to 
be considered as a potential drug candidate, the logistics of its supply must be assessed.  
Thus, it is desirable to know the cellular origin of the natural product when considering 
available options for large scale production.  Having established the source of a 
bioactive molecule, production via tissue culture or genome transfer becomes an option.  
This would serve to ameliorate the supply problems of compounds which typically 
occur at extremely low levels in the source organisms, and also greatly simplify the 
extraction process.  Ecological considerations are also relevant here.  Further research 
has indicated that marine organisms may synthesise bioactive molecules on demand for 
the purpose of chemical defence against predation and epibiosis.2,3  Thus, it may be 
possible to manipulate an organism in order to optimise its production of bioactive 
molecules. 
Cell separation techniques have been applied to the Chatham Rise sponge 
Lamellomorpha strongylata (Order Epipolasida, Family Jaspidae) and the Kaikoura 
sponge Lissodendoryx sp. (Order Poecilosclerida, Family Myxillidae).  A sample of 
Lamellomorpha strongylata collected from Spirits Bay, Northland, will also be 
discussed. 
 
 
Figure 2.1.1  Map of New Zealand showing the collection 
sites at (a) Spirits Bay, (b) Kaikoura and (c) the Chatham Rise. 
Image courtesy of NIWA. 
 
 
 
a 
b 
c 
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2.2  Lamellomorpha strongylata 
 
Figure 2.2.1  Lamellomorpha strongylata.  Image courtesy of Marine Group photo archive, University of 
Canterbury. 
A wide variety of compounds have been isolated from the sponge Lamellomorpha 
strongylata, collected in deep water (80-100m) on the Chatham Rise, including the 
known cytotoxic calyculins A (2.1), B (2.2), E (2.5) and F (2.6), the new cytotoxic 
compounds calyculinamide A (2.3) and B (2.4) and swinholide H (2.7), as well as 
several novel theonellapeptolides (e.g. 2.8).18,19 
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It would be interesting to know if all of these compounds could be isolated from sponge 
cells or if they would be found in cells of symbiotic bacteria.  The aim of this section of 
work was to locate these compounds within discrete cell types. 
2.2.1  Introductory analyses 
Six duplicate (twelve in total) samples of Lamellomorpha strongylata were preserved in 
fixative by a Post Doctoral Fellow in the Marine Group, Eric Dumdei, in 1987.  In each 
set of six samples, three were diced sponge pieces and three were whole pieces of 
sponge.  Various combinations of formaldehyde, glutaraldehyde and cacodylate were 
used as the fixative. 
The first work carried out on this sponge was a microscopic examination (100 x, 
immersion) of the twelve fixed sponge samples.  The most striking feature of these 
samples was the presence of large quantities of filamentous heterotrophic bacteria, 
which were observed throughout the organism (Fig. 2.2.2). 
 
Figure 2.2.2  SEM image of the filamentous bacteria observed in Lamellomorpha strongylata, where the 
average segment length of the filaments is 4 µm 
In order to assess the feasibility of detecting the secondary metabolites found in 
Lamellomorpha strongylata in a crude extract, a sub-sample from the early stages of an 
extraction carried out by Eric Dumdei was analysed by analytical HPLC on ODS-silica 
(methanol/water, 9:1).  In this extraction, 800 g of sponge (95CR 2-16) was blended in 
600 mL methanol/water (4:1) for 5 minutes.  The resultant slurry was left to stand for 20 
minutes, before being filtered through celite under vacuum.  The resultant filtrate was 
then stored in a freezer.  I transferred 0.5 mL of this filtrate into an aluminium foil-
covered vial in order to preserve the light sensitive calyculins and calyculinamides, and 
analysed it by HPLC on an analytical ODS-silica column (methanol/water, 9:1).  Peaks 
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in the HPLC spectrum corresponding to theonellapeptolide IIId and IIIe (2.8) were 
apparent, at retention times of 15.01 and 18.31 minutes (at 216 nm), respectively.  Low 
level peaks at the correct retention times for calyculinamide A (2.3) and B (2.4) (with 
retention times of 4.21 and 4.48 minutes (at 340 nm), respectively) and for calyculin A 
(2.1) and B (2.2) (which co-elute in 90% methanol/water at 5.65 minutes (340 nm)) 
were observed.  Another low level peak eluting at 28.89 minutes (at 270 nm) indicated 
the presence of a swinholide.  Standard samples of these compounds were run 
immediately after the crude sponge extract.  Excellent agreement in retention times was 
observed in all cases. 
In order to establish the continued presence of the secondary metabolites under the 
conditions of the fixative, a whole portion (0.96 g) of fixed sponge was extracted and 
analysed.  The sponge material was minced, sonicated in distilled water, freeze-dried, 
ground and then extracted with methanol and dichloromethane.  The resultant extract 
was dried under nitrogen, and analysed by 1H NMR spectroscopy and analytical HPLC 
on ODS-silica (methanol/water, 9:1).  Light protection was achieved throughout this 
extraction with the use of aluminium foil. 
Low level signals were observed in the 1H NMR spectrum which may be consistent 
with the presence of swinholide-like and theonellapeptolide-like compounds.  However, 
stronger evidence in support of the presence of these compounds was obtained from the 
HPLC spectrum.  UV maxima at expected retention times for theonellapeptolide IIId 
and IIIe (2.8) (14.98 and 18.21 minutes at 216 nm, respectively) and a swinholide 
(28.79 minutes at 270 nm) were observed.  No calyculin- or calyculinamide-like 
material was detected by either spectroscopic technique.  It was initially thought that 
this might be due to acetal formation in these compounds in the presence of 
formaldehyde (Fig. 2.2.3).  However, if acetal formation had occurred, peaks should 
still be observed at 340 nm in the HPLC spectrum, but with slightly different retention 
times than those for the calyculins and calyculinamides.  No peaks were seen at this 
wavelength, suggesting that the calyculins and calyculinamides are being degraded 
under the conditions of the fixative. 
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Figure 2.2.3  Mechanism for the formation of a cyclic methylene acetal in the presence of formaldehyde 
in molecules containing a 1,3 diol functionality, such as the calyculins and the calyculinamides 
 
2.2.2  Analysis of the filamentous bacteria 
One of the diced fixed sponge samples was selected for initial cell dissociation studies.  
This sample (10.43 g) was washed three times in calcium-magnesium free artificial 
seawater (CMF-ASW) to remove all traces of the fixative.  Calcium and magnesium are 
excluded from the artificial seawater as they promote cell aggregation.  The sample was 
then dissociated in a small Virtis blender for three time intervals of two minutes each in 
CMF-ASW.  The resultant slurry was examined under a microscope (100 x, immersion) 
after each two minute period in order to monitor the extent of dissociation.  It was then 
filtered through 75 µm mesh in order to remove any clumps of undissociated cells 
which might be present.  The material retained on the filter was re-examined under the 
microscope.  As there were still large quantities of undissociated filamentous and 
sponge cells apparent, this material was returned to the Virtis, blended for a further ten 
minutes in CMF-ASW, then re-filtered through 75 µm mesh. 
The filtered dissociated cells were combined, and centrifuged at 1100 rpm (200 x g) for 
five minutes.  Close inspection of the resultant pellet showed the formation of two 
layers.  These layers were separated by repeatedly swirling off and re-centrifuging the 
top layer (filamentous bacteria) from the bottom layer (spicules and clumps of 
undissociated yellow sponge cells).  The resultant homogeneous sample of filamentous 
heterotrophic bacteria cells was centrifuged twice more in Milli-QÒ H2O in order to 
remove the CMF-ASW.  All the supernatants from above the pellets were combined and 
stored for subsequent analysis.  A sub-sample of the filamentous heterotrophic bacteria 
cells was removed for reference and stored in CMF-ASW.  The remainder of the sample 
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was freeze-dried and ground to give 144.6 mg of material.  This was sonicated in 
methanol for five minutes and then passed through a 0.2 µm filter.  The material 
collected on the filter was extracted and filtered twice more, and the filtrates combined 
and dried under nitrogen to give a 7.4 mg sample.  This was analysed by 1H NMR 
spectroscopy and analytical HPLC on ODS-silica (methanol/water, 9:1).  Light 
protection was achieved throughout with the use of aluminium foil. 
Signals in the 1H NMR spectrum consistent with the presence of theonellapeptolides, 
including those due to amide protons of the amino acids above 6.5 ppm, were apparent 
(Fig 2.2.4).  The presence of theonellapeptolides IIId and IIIe (2.8) was also indicated 
by the HPLC spectrum (Fig 2.2.5), with the observance of signals with retention times 
of 17.11 and 20.90 minutes, respectively (at 216 nm).  No evidence indicating the 
presence of calyculins, calyculinamides or swinholides was found. 
ppm12345678  
ppm12345678  
Figure 2.2.4  1H NMR spectra of theonellapeptolide IIIe (top) and the homogeneous filamentous 
heterotrophic bacteria sample (bottom) 
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Figure 2.2.5  HPLC chromatogram of the homogeneous sample of filamentous heterotrophic bacteria 
cells at 219 nm showing theonellapeptolides IIId (a) and IIIe (b) (2.8) 
 
Purification of the components of the filamentous bacteria extract was then carried out 
via preparative HPLC on ODS-silica (MeOH/H2O, 9:1).  Three peaks were collected 
(fractions 3-5) and dried down to give 1.8, 1.3 and 3.8 mg of material, respectively.  The 
fractions were then analysed via 1H NMR spectroscopy, analytical HPLS on ODS-silica 
(MeOH/H2O, 9:1) and LRFABMS.  The 1H NMR spectra of these three fractions 
indicated the presence of peptide-like compounds.  From the retention times of fractions 
3 and 5 in the HPLC spectra (17.11 and 20.90 minutes, respectively (at 216 nm)), 
fraction 3 was identified as theonellapeptolide IIId and fraction 5 as theonellapeptolide 
IIIe (2.8).  This was confirmed by LRFABMS.  (Theonellapeptolide IIId (fraction 3): 
LRFABMS, m/z 1536.9 [M + Cs]+ (calcd for C70H125N13O16Cs, 1536.8); 
theonellapeptolide IIIe (fraction 5): LRFABMS, m/z 1550.9 [M + Cs]+ (calcd for 
C71H127N13O16Cs, 1550.9)).  Fraction 4 appears to be an unknown theonellapeptolide.  It 
eluted at 19.11 minutes (216 nm) and was determined to be isobaric with 
theonellapeptolide IIIe (2.8) by LRFABMS. 
The filamentous bacteria stained Gram positive.  Scanning electron microscopy (SEM) 
and transmission electron microscopy (TEM) was carried out on a pure sample of the 
filamentous heterotrophic bacteria.  Two of the resultant micrographs are shown in 
Figure 2.2.6. 
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    (a)       (b) 
 
 
 
 
Figure 2.2.6  SEM (a) and TEM (b) micrographs of filamentous heterotrophic bacteria from 
Lamellomorpha strongylata (~ 4 µm segment length) 
 
2.2.3  Analysis of the sponge cells 
The combined supernatants from above the pellets formed on centrifugation of the 
dissociated cells at 1100 rpm (200 x g) were re-centrifuged at 1900 rpm (600 x g) for 5 
minutes in an attempt to obtain a sample of dissociated sponge cells.  Microscopic 
inspection of the resultant pellet (100 x, immersion) revealed extensive contamination 
of the sample with single segments of the filamentous bacteria and no obvious sponge 
cells.  The problems encountered with this sample are likely to be a result of 
dissociating fixed sponge, rather than blending and filtering fresh sponge and then 
fixing the resultant cells.  Extensive blending was required in order to obtain a 
reasonable quantity of dissociated filamentous bacteria cells.  Any sponge cells that 
were dissociated in this process could well have been destroyed by subsequent blending.  
In addition, undissociated sponge cells were noted in the material retained on the filter 
after blending, as well as in the lower layer of the pellet obtained after centrifugation at 
1100 rpm.  No further work was carried out on this sample. 
Unfortunately, due to considerable logistical constraints involved in the collection of the 
sponge from the Chatham Rise, and the need to process the material immediately 
following its collection, it was not possible to obtain fresh sponge to continue this work. 
 
2.2.4  Analysis of the unicellular bacteria 
The combined supernatants from above the pellets formed on centrifugation of the 
dissociated cells at 1900 rpm (600 x g) were re-centrifuged at 5000 rpm (4100 x g) for 5 
minutes.  The resultant pellets were inspected under a microscope (100 x, immersion).  
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This again revealed contamination from single segments of the filamentous bacteria, but 
to a lesser extent than that seen in the 1900 rpm pellet.  The pellets were combined and 
re-centrifuged in Milli-QÒ H2O.  An upper yellow-coloured layer and a lower black-
coloured layer were observed in the resultant pellet.  Microscopic investigation showed 
that the lower layer was comprised of spicule fragments, single segments of filamentous 
bacteria (along with a few short chains) and a small quantity of sponge cells.  The upper 
layer consisted of very small cells (~ 1 µm in diameter), which were identified as 
unicellular bacteria.  The two layers were separated by repeatedly swirling off and re-
centrifuging (in Milli-QÒ H2O) the top less-densely pelleted layer.  The resultant pellet 
was freeze-dried, ground, sonicated in MeOH for 20 minutes, filtered through a 0.2 µm 
filter, and dried under N2 to give a sample of 2.5 mg.  This was analysed by 1H NMR 
and analytical HPLC on ODS-silica (MeOH/H2O, 9:1).  Light protection was achieved 
throughout with the use of aluminium foil. 
The presence of theonellapeptolides was apparent in the HPLC spectrum, as expected, 
due to contamination of the sample with single segments of filamentous heterotrophic 
bacteria.  However, the presence of a swinholide was also indicated in this spectrum 
(Fig. 2.2.6), with the observance of a peak eluting at 32.5 minutes (270 nm).  This 
retention time was not indicative of swinholide H (2.7), however, which elutes at 31.9 
minutes.  It was postulated that this swinholide could be swinholide dimethylene acetal 
(2.9), formed as a result of the presence of formaldehyde in the fixative used (Fig. 
2.2.3). 
       
 
 
 
 
 
Figure 2.2.6  HPLC chromatogram of the unicellular bacteria sample at 270nm (blue) showing 
swinholide H dimethylene acetal (2.9) eluting at 32.5 minutes, overlaid with that of swinholide H (black) 
(2.7), which elutes at 31.9 minutes 
Analysis of the 1H NMR spectrum (run in CDCl3) revealed swinholide-like resonances, 
along with low level peptide signals.  The swinholide-like resonances were consistent 
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with the presence of swinholide H dimethylene acetal (2.9), by comparison with those 
for both swinholide H (2.7) and swinholide H diacetonide (2.10).  As the 1H NMR 
spectrum was done on the whole extract obtained from the unicellular bacteria cell 
pellet, only the most intense signals belonging to the swinholide-like material were 
apparent.  The chemical shifts of these 1H NMR signals are presented in Table 2.2.1, 
along with the corresponding signals for swinholide H (2.7) and swinholide H 
diacetonide (2.10). 
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From the observed 1H NMR chemical shifts (Table 2.2.1), it appears that the H13 and 
22-Me protons in swinholide H dimethylene acetal are in environments which bear 
more resemblance to those in swinholide H than its diacetonide, whilst the opposite is 
true of the 15-OMe, 16-Me, 20-Me and 24-Me protons in swinholide H dimethylene 
acetal, whose environments are more akin to the corresponding protons in swinholide H 
diacetonide.  In order to gain some insight into the three dimensional structures of the 
swinholides in question, the X-ray coordinates for swinholide A72 were imported into 
Chem3D ProTM.  The changes required to obtain the structures for swinholide H (13), 
swinholide H dimethylene acetal (15) and swinholide H diacetonide (16) were made on 
the resultant 3D structure, and each was then energy minimised.  The 3D arrangement 
of the atoms in each molecule was then compared.  This indicated that the H13 and 22-
Me protons in swinholide H dimethylene acetal are in environments similar to those in 
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swinholide H, and the 15-OMe, 16-Me, 20-Me and 24-Me protons in swinholide H 
dimethylene acetal are in environments similar to the corresponding protons in 
swinholide H diacetonide, thus supporting the observed chemical shifts shown in Table 
2.2.1. 
Confirmation of the presence of swinholide H dimethylene acetal (2.9) was obtained by 
LRFABMS (m/z 1440.9 [M], calcd for C82H136O20, 1440.96).  Scanning electron 
microscopy (SEM) and transmission electron microscopy (TEM) was carried out on a 
sample of the unicellular bacterium from Lamellomorpha strongylata.  A TEM 
micrograph is shown in Figure 2.2.7. 
 
Table 2.2.1  1H NMR (300 MHz) chemical shift data for swinholide H (2.7), swinholide H dimethylene 
acetal (2.9) and swinholide H diacetonide (2.10)a 
position 2.7 2.9 2.10 
13 3.48 3.48 3.62 
7-OMe 3.43 3.42 3.41 
15-OMe 3.36 3.29 3.29 
29-OMe 3.33 3.33 3.33 
4-Me 1.82 1.82 1.82 
16-Me 0.80 0.75 0.74 
20-Me 0.93 0.87 0.89 
22-Me 0.85 0.85 0.82 
24-Me 0.96 1.00 0.99 
31-Me 1.19 1.20 1.19 
aValues in ppm relative to CHCl3 (d7.26). 
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Figure 2.2.7  TEM micrograph of a unicellular bacterium from Lamellomorpha strongylata (~ 1 µm 
length) 
 
2.2.5  Geographically distinct population of Lamellomorpha strongylata 
Another sample of Lamellomorpha strongylata was subsequently supplied by the 
National Institute of Water and Atmospheric Research (NIWA).  This was a frozen 
sample that had been collected at Spirits Bay, Northland, New Zealand.  Like the 
Chatham Rise specimen, it was also reported to contain filamentous heterotrophic 
bacteria, but had no biological activity.  Microscopic analysis revealed the presence of 
filamentous bacteria in low levels only (in comparison to that associated with the 
Chatham Rise specimen), and apparently only on the surface of the sponge.  TEM 
analysis of the bacteria from the northern Lamellomorpha strongylata was undertaken, 
however the cells had unfortunately been damaged in the freezing process, as feared.  
This prohibited any meaningful comparison of the filamentous bacteria from the two 
geographically distinct populations of Lamellomorpha strongylata. 
 
2.2.6  Summary and future directions 
The theonellapeptolides isolated from Lamellomorpha strongylata have been located in 
the sponge-associated filamentous heterotrophic bacteria, while a swinholide has been 
found in symbiotic unicellular bacteria.  Two of the known theonellapeptolides, IIId and 
IIIe (2.8), were identified via 1H NMR, HPLC and LRFABMS, along with another 
unreported theonellapeptolide isobaric with IIIe.  The swinholide was identified as 
swinholide H di-methylene acetal (2.9) via an analysis of its 3-D structure, a 
comparison of its NMR data with that obtained for swinholide H diacetonide (2.10) and 
MS data.  These findings are consistent with research carried out on the Lithistid sponge 
Theonella swinhoei from Palau, where a peptide (P951) and swinholide A were found to 
be located solely in associated filamentous heterotrophic bacteria and unicellular 
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heterotrophic bacteria, respectively.  In this case, no major metabolites were located in 
the sponge cells or in the cyanobacterial cells, which were the final two of four discrete 
cell populations observed in the sponge.25 
Should a sufficient quantity of live Lamellomorpha strongylata become available in the 
future, it would be interesting to attempt cell dissociation of the sponge and associated 
symbionts without the use of chemical fixatives, in order to localise the calyculins and 
calyculinamides (which are suspected to degrade in the presence of fixative) within 
discrete cell populations.  Dissociation of whole fixed sponge was not conducive to the 
obtention of intact sponge cells, so dissociation of fresh sponge is likely to achieve a 
higher yield of sponge cells for analysis.  These cells could be preserved in liquid 
nitrogen and then separated into homogeneous cells types quickly, using centrifugation 
or density gradients, without the use of fixatives.  Alternatively, microwave fixation 
may be an option.  In the event that one or more of the secondary metabolites are 
located in sponge cells, ecological experiments, involving wounding or the introduction 
of parasites to the sponge, for example, could then be carried out in order to determine 
whether or not production of the bioactive molecule(s) is enhanced by placing the 
source organism under environmental stress.  Aquaculture trials to determine optimal 
conditions for sponge growth and secondary metabolite production could also be 
undertaken. 
Although it seems likely that the sponge-associated filamentous heterotrophic bacteria 
and unicellular bacteria are the producing organisms of the theonellapeptolides and 
swinholides, respectively (Ockham’s razor states the simplest solution tends to be the 
correct one), it is possible that the localisation of the compounds within these cells may 
be misleading, and that they are merely being stored in the cells in question.  Genetic 
studies to identify the producing gene cluster, such as is currently being explored in 
several groups around the world, would clarify this point.73 
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2.3  Lissodendoryx sp. 
 
Figure 2.3.1  Lissodendoryx sp..  Image courtesy of Marine Group photo archive, University of 
Canterbury. 
 
A major hurdle for the development of the halichondrins as anticancer drugs has been 
the supply issue.  Kishi’s total synthesis of halichondrin B published in 1992 is still the 
only method reported to date, but as it involves close to 50 steps in the longest linear 
sequence it is not likely to be an economically viable option for the supply of the 
halichondrins.36  However, more recently it has been found that a portion of the right 
hand side of the molecule retains the activity of the whole (see chapter 3 (3.12)), thus 
opening up the possibility of a commercially viable synthesis of this smaller molecule.  
In addition, Kishi’s group at Harvard University, along with other synthetic groups 
including that of Steven Burke at the University of Wisconsin-Madison, continue to 
publish syntheses of portions of halichondrin B in fewer steps and with higher yields, 
and exciting progress is being made in Andrew Phillips’ group at the University of 
Colorado at Boulder on a total synthesis of the halichondrins in under 30 steps.74 
Another option that has been investigated for the large scale production of the 
halichondrins is aquaculture.  Initial aquaculture trials have indicated variable levels of 
the halichondrins in the sponge as a result of differing environmental conditions.75  
These trials also suggest, however, that enhanced production of the compounds can be 
achieved by stressing the sponge.  The establishment of the cellular location of the 
halichondrins in the sponge itself, or in its microbial symbionts, is therefore extremely 
pertinent. 
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2.3.1  Microscopic analysis 
Six small samples of fixed Lissodendoryx sp. (I 1-3 and II 1-3) were supplied by NIWA.  
Microscopic investigation (100 x, immersion) of the fixative solutions revealed cell 
debris only, with no sign of intact sponge cells.  Small slices of each sample were taken, 
washed three times in CMF-ASW, and inspected under the microscope.  Intact sponge 
cells were found in all six samples.  Samples I 1-3 and II 1-3 were combined to give two 
larger samples (I and II), and dissociated with a razor blade.  The two samples were then 
filtered through 100 µm mesh in order to remove any clumps of undissociated cells, and 
made up to ~7 mL with CMF-ASW.  Six 10 mL discontinuous PercollÒ gradients were 
prepared, by sequentially layering 2 mL of 60%, 45%, 30%, 15% and 5% PercollÒ, in 
CMF-ASW, into centrifuge tubes.  Samples I and II (3 x 2 mL from each) were then 
loaded onto the top of the density gradients, and centrifuged at 600 rpm for 10 minutes.  
Bands of cells were apparent at the density interfaces of the PercollÒ layers.  These were 
isolated individually by pipette, and combined in each series (I and II) to give samples I 
1-8 and II 1-6.  These samples were centrifuged twice in fresh CMF-ASW in order to 
remove the PercollÒ, and investigated microscopically. 
In series I, most of the cellular material was located in samples 1-3.  Cell debris, 
collagen, archeocytes, and very small cells (possibly bacteria clumps) were found in 
sample 1.  Sample 2 contained a few clumps of undissociated cells, along with 
choanocytes, archeocytes, spherulous cells and pinacocytes.  Larger cells still were 
found in sample 3 (choanocytes, archeocytes and spherulous cells, plus at least three 
other cell types).  Samples 4-7 had much lower cell densities than the earlier samples, 
containing decreasing quantities of archeocytes and spherulous cells, along with spicule 
fragments.  Sample 8 consisted mainly of “rocks” (bits of stone quartz chips, and 
spicules). 
In series II, very small archeocytes, collagen and possibly bacteria cells were again 
found in sample 1.  Sample 2 contained choanocytes, archeocytes, cell debris and a few 
spherulous cells.  Cell size continued to increase into sample 3, with the presence of 
archeocytes, spherulous cells, choanocytes and pinacocytes.  Samples 4 and 5 contained 
progressively larger archeocytes, and sample 6 again consisted mainly of “rocks”. 
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2.3.2  Analysis of fixed sponge material 
Four additional fixed sponge samples, each in a different fixative, were subsequently 
supplied by NIWA for assessment of the survival of the halichondrins when exposed to 
fixative.  The fixatives used were Davidson’s, IG4F, 10% formaldehyde, and 1.9% 
formaldehyde/1.5% glutaraldehyde.  A series of experiments involving soaking and 
washing samples of this fixed sponge material (in both CMF ASW and distilled water) 
and extracting it before submitting samples for assay indicated that detection of the 
halichondrins in fixed sponge via the P388 assay was not possible due to the activity of 
the fixatives themselves in the assay and the difficulty in effectively removing the 
fixatives from the sponge material.  Thus, spectroscopic detection (NMR, HPLC, MS) 
is required. 
Spectroscopic investigations of extracts of these four samples of fixed Lissodendoryx 
sp. were inconclusive.  Although halichondrin-sized molecules were detected by MS 
analysis, the presence of the halichondrins was not able to be confirmed by 1H NMR 
due to insufficient quantities in the small samples supplied to date. 
4 g samples of each of the four Lissodendoryx sp. fixed sponge samples were taken.  
Each was chopped with a razor blade, sonicated in Milli-QÒ H2O, freeze dried and 
placed on the hi-vac for 8 hours.  The samples were then weighed, ground, extracted 
with 25 mL 3:1 MeOH:CH2Cl2, and centrifuged at 3000 rpm for 10 minutes.  
Spectroscopic investigations of these four samples were inconclusive.  All four samples 
showed evidence of halichondrin-sized molecules by MS, however no exact match to 
any of the known halichondrins was observed.  The presence of the halichondrins was 
not able to be confirmed by 1H NMR due to insufficient quantities in the samples 
available.  This may not have been the case had the Capillary NMR probe, used in the 
analyses discussed in Chapter 3, been available at the time this work was done.  
Degradation of the samples over time meant that it was not possible to re-analyse the 
samples after the purchase of the CapNMR probe. 
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2.3.3  Summary and future directions 
Halichondrin-sized molecules have been observed in samples of fixed Lissodendoryx 
sp., however definitive identification has not yet been achieved.  As was encountered in 
the dissociation of Lamellomorpha strongylata, dissociation of the sponge 
Lissodendoryx sp. after fixation proved to be very destructive of the sponge cells 
present.  Ideally, the sponge should be dissociated fresh, and the resultant cells 
preserved in liquid nitrogen.  These cells could subsequently be fixed, once it has been 
established that the halichondrins survive exposure to the fixatives used.  Alternatively, 
microwave fixation could be investigated, or the cells could be studied quickly without 
fixation. 
Once a suitable protocol has been established, further investigation is needed on larger 
quantities of sponge in order to enable spectroscopic identification (via analytical HPLC 
on ODS-silica, 1H NMR and MS) of the halichondrins in homogenous cell samples, 
obtained via centrifugation and/or PercollÒ density gradients.  Determination of the cell 
type in which the halichondrins are located, by SEM and TEM, should then be 
undertaken.  The identification of particular halichondrins and their relative abundance 
should also be possible. 
Chapter 3.  New Halichondrins  46 
CHAPTER 3.  New Halichondrins. 
 
3.1  Introduction 
An ongoing project in the Marine Chemistry Group at the University of Canterbury has 
been a study of the halichondrin series of compounds (complex polyether macrolides) 
which were first isolated from the Japanese sponge Halichondria okadai Kadota.32,33  
The major halichondrin component isolated from this sponge, and the first to be 
characterised, was norhalichondrin A (3.1). 
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The halichondrins are classified in three series (A, B or C) according to the degree of 
oxygenation at the C12 and C13 positions of the tricyclo ring system. 
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These compounds have subsequently been isolated from other sponges, including B 
series halichondrins from the bright yellow sponge Lissodendoryx sp. (Family 
Myxillidae, Order Poecilosclerida) which is found in deep water (~ 100 m) off the 
Kaikoura Peninsula.76 Although still occurring at very low levels, relatively speaking 
the Kaikoura source of the halichondrins is rich.  Lissodendoryx sp. has been found to 
contain approximately 1.6 mg of total halichondrins per kg of wet sponge.  Two of the 
known halichondrins isolated from the Kaikoura sponge, halichondrin B (3.2) and 
isohomohalichondrin B (3.3), have been investigated by the National Cancer Institute 
(NCI) in the USA and the pharmaceutical company PharmaMar S.A. in Spain, 
respectively, for their extremely promising anticancer activity.  Halichondrin B is an 
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antimitotic agent, active against selected sensitive melanoma, colon, ovarian, lung and 
breast cancer cell lines. 
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In addition to halichondrin B (3.2) and isohomohalichondrin B (3.3), the other known 
halichondrins isolated to date from Lissodendoryx sp., which are all from the B series, 
are shown below (3.4 – 3.11).  Compounds 3.5, 3.10 and 3.11 are thought to be artefacts 
of the isolation process.76 
Following the total synthesis of halichondrin B (3.2) and norhalichondrin B (3.1) in 
1992,36 it was discovered that synthetically derived analogues based on the fragment 
from C1 to C30 had cytotoxic activity similar to that of halichondrin B.77-83  One of 
these simplified analogues, the macrocyclic ketone NSC 707389 (3.12), is currently in 
clinical trials, having replaced halichondrin B as the lead candidate of this class of 
compounds due to its comparable activity and relative ease of supply.38  In further 
studies, NSC 707389 was found to be consistently more potent than halichondrin B in 
its interactions with tubulin.38  
 
 
Chapter 3.  New Halichondrins  48 
O
O
O
O
O
O
O
O
O O
O
O
O
O
O
CH3
CH3 H
H
H
H
CH3
H
H
CH3
3.4  homohalichondrin B
1 3
12
19
26
3844
O
O
HO
HO
54
O
CH3
44
O
3.5  38-epi isohomohalichondrin B (artefact)
HO
OHO
53
O
CH3
44
O
3.6  norhalichondrin B
HO
CO2H
O 44
3.7  neonorhalichondrin B
O
CH3
HO
OH
OH
48
51
O
CH3
44
3.8  neohomohalichondrin B
OHO
HO
OH
51
48
O
CH3
44
O
3.9  55-methoxyisohomohalichondrin B
CH3O
OHO
53
48 O
CH3
44
O
53
48
3.11  53-epi 53-methoxyneoisohomohalichondrin B
OHO
H3CO
(artefact)
48
48 48
3.10  53-methoxyneoisohomohalichondrin B
(artefact)
O
O O
O
O
O
O
O
CH3
H
H
3.12  NSC 707389
1 3
12
19
26
O
H3CO
H2N
HO
34
 
 
Chapter 3.  New Halichondrins  49 
3.2  Isolation of new halichondrins from Lissodendoryx sp. 
The halichondrins occur at extremely low levels in Lissodendoryx sp.  One tonne of the 
sponge was collected in 1995 in order to supply halichondrin B (310 mg) and 
isohomohalichondrin B (~300 mg) for further trials.  During the final purification of 
isohomohalichondrin B by preparative HPLC on ODS-silica (CH3CN/H2O, 7:3 or 9:1), 
twelve 2.5 L bottles of side cut residue were accumulated.  The residue from each of 
these bottles was dried down individually, weighed, and analysed by 1H NMR and 
analytical HPLC on ODS-silica (CH3CN/H2O, 7:3 and 9:1).  Signals in the 1H NMR 
spectra characteristic of the halichondrins (for example, those between 4.7 and 5 ppm 
corresponding to the 19=CH2 and 26=CH2 exocyclic methylenes) were observed in the 
extracts of all twelve bottles.  In the HPLC spectra, halichondrin-like peaks, which 
exhibit end absorption only, were also seen. 
This side cut residue was processed, after initial analysis with DIOL TLC (4% 
MeOH/CH2Cl2), on preparative and analytical HPLC ODS-silica columns, eluting with 
55% CH3CN/H2O and 70% CH3CN/H2O respectively, to give five pure fractions (SH3 
116.2, 116.4, 118.2, 118.3 and 118.4).  Analysis of these fractions via analytical HPLC 
on ODS-silica (CH3CN/H2O, 7:3), 1H NMR and LCMS established that these were all 
new halichondrins.  Table 3.2.1 depicts the masses of the five new halichondrins, 
interspersed with those of the known halichondrins.  The HPLC chromatograms of the 
five new halichondrins are shown in Figure 3.2.1. 
Using a 5 mg/mL solution of quinine in the 1H NMR solvent (deuterated chloroform 
containing 0.1% d5-pyridine), it was established that there were approximate sample 
sizes of between 50 and 110 µg.  The quantity of the compounds was estimated 
according to the formula:  
(MW/#H) x (total integral for #H)/(integral for CHCl3) x CF 
where MW is the molecular weight of the compound, #H is the number of protons in the 
selected resonances used, “total integral for #H” is the sum of the integrals for the 
selected resonances, and CF is the calibration factor that had previously been 
determined from a standard solution containing quinine (5 mg/mL) in the same CDCl3 
solvent.  #H was typically ~10, with resonances selected on the basis of their resolution 
from other resonances and from the solvent peak. 
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Using these estimated masses, the five samples were submitted for P388 assay (a 
murine leukaemia cell line) at known concentration, yielding results in ng/mL.  All five 
of the new halichondrins showed very potent P388 activity.  Individual sample masses, 
along with their P388 activities, are given in Table 3.2.2.  The P388 activities of three 
known halichondrins are also included for the purpose of comparison. 
Table 3.2.1  Exact masses of the halichondrins isolated from Lissodendoryx sp. 
Compound Number Exact Mass 
SH3 116.2 3.13 1020.51 
SH3 118.2 3.15 1076.53 
SH3 118.3 3.16 1092.57 
norhalichondrin B 3.6 1094.54 
neonorhalichondrin B (minor 2) 3.7 1096.56 
SH3 118.4 3.17 not determined 
halichondrin B 3.2 1110.58 
homohalichondrin B 3.4 1122.58 
isohomohalichondrin B 3.3 1122.58 
38-epi isohomohalichondrin B (artefact) 3.5 1122.58 
neohomohalichondrin B (minor 1) 3.8 1124.59 
55-methoxyisohomohalichondrin B (LP2) 3.9 1136.59 
53-methoxyneoisohomohalichondrin B (LP1) 3.10 1136.59 
53-epi 53-methoxyneoisohomohalichondrin B (LP3) 3.11 1136.59 
SH3 116.4 3.14 1140.54 
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Figure 3.2.1  The ELSD HPLC chromatograms of the SH3 116.x (black) and SH3 118.x (blue) series of 
new halichondrins, with retention times in minutes 
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Table 3.2.2  Estimated sample masses and in vitro cytotoxicities of selected halichondrins 
Compound Sample Mass (µg) P388 IC50 (ng/mL) 
SH3 116.2 50 1.1 
SH3 116.4 55 2.0 
SH3 118.2 110 1.1 
SH3 118.3 88 0.76 
SH3 118.4 50 0.51 
halichondrin B  0.78 
homohalichondrin B  0.22 
isohomohalichondrin B   0.18 
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3.3  Structure elucidation of SH3 116.2 (3.13) 
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SH3 116.2 (3.13) was the second most polar of the five new halichondrin derivatives 
(Fig. 3.3.1).  High-resolution LCMS (m/z 1038.5372 [M+NH4]+, Δ = -5.4 mmu), in 
combination with NMR data (Table 3.3.1), gave the molecular formula C56H76O17 (19 
double bond equivalents).  This is 90 mass units less than that observed for halichondrin 
B (3.2), corresponding to the replacement of the terminal chain from carbon 51 in 
halichondrin B with a carboxyl moiety, thus converting the terminal ring to a γ-lactone.  
The NMR assignments were confirmed by gCOSY, TOCSY, ROESY and HSQC 2D 
experiments, in addition to comparisons with the known NMR shifts for halichondrin B.  
The 1H NMR spectrum is shown in Figure 3.3.1.  Due to the small sample size, no 13C 
NMR spectrum was obtained.  The 13C data reported in Table 3.3.1 were obtained from 
the HSQC experiment (Fig. 3.3.2). 
The observed 1H NMR shifts for SH3 116.2 showed excellent agreement with those of 
halichondrin B up to C45 (Table 3.3.1).  The connectivity of the remainder of the 
molecule was established via gCOSY and TOCSY data (Fig. 3.3.3).  The presence of a 
large geminal coupling constant of 17 Hz for the methylene protons at C49 (δ 2.50, 
2.66) is consistent with the attachment of a carboxyl moiety at C50.84 
H47 (δ 4.21) and H48 (δ 4.26) were determined to be cis from the small 2 Hz coupling 
constant observed for H48, and the relative stereochemistry of these protons was 
established via observed ROESY correlations between H46 (δ 2.43) and both H47 and 
H48 (Fig. 3.3.3).  This stereochemistry is consistent with that observed for halichondrin 
B (3.2).  The gCOSY, TOCSY and ROESY spectra, along with selected correlations, 
are shown in Figures 3.3.4, 3.3.5 and 3.3.6, respectively. 
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Table 3.3.1  1H and 13C NMR chemical shift data for halichondrin B (3.2) and SH3 116.2 (3.13)a 
    halichondrin B   SH3 116.2 
position   C   H   Cb   H 
1  171.2    c   
2  40.4  2.35, 2.60  40.4  2.35, 2.59 
3  73.7  3.86  73.7  3.88 
4  30.7  1.37, 1.75  30.6  1.38, 1.75 
5  30.0  1.35, 2.08  30.0  1.37, 2.09 
6  68.2  4.34  68.3  4.33 
7  77.7  2.94  77.7  2.94 
8  74.3  4.33  74.3  4.32 
9  73.8  4.04  73.8  4.05 
10  76.5  4.20  76.5  4.19 
11  82.1  4.60  82.1  4.59 
12  81.1  4.68  81.1  4.68 
13  48.3  1.94, 2.15  48.3  1.94, 2.16 
14  110.1    c   
15  34.4  1.62, 2.18  34.4  1.62, 2.16 
16  28.2  1.42, 2.16  28.2  1.43, 2.17 
17  75.5  4.10  75.2  4.10 
18  38.7  2.26, 2.80  38.6  2.27, 2.79 
19  151.8    c   
19=CH2  104.4  4.92, 4.98  c  4.91, 4.99 
20  75.4  4.37  75.3  4.37 
21  29.5  1.40, 1.88  29.6  1.40, 1.88 
22  32.0  1.60, 1.60  32.0  1.61, 1.61 
23  74.9  3.53  74.8  3.54 
24  43.4  1.04, 1.70  43.4  1.04, 1.70 
25  35.9  2.20  36.0  2.20 
25-Me  18.0  1.07  18.0  1.07 
26  151.6    c   
26=CH2  104.2  4.77, 4.81  c  4.76, 4.81 
27  73.5  3.54  73.5  3.53 
28  36.9  1.94, 2.02  36.9  1.94, 2.02 
29  71.2  4.21  71.2  4.21 
30  76.9  4.63  76.9  4.65 
31  36.6  2.04  36.5  2.04 
31-Me  15.1  0.99  15.0  1.00 
32  77.5  3.18  77.5  3.19 
33  66.3  3.80  66.3  3.81 
34  29.1  1.79, 2.13  29.1  1.80, 2.13 
35  75.0  4.10  75.2  4.10 
36  76.2  4.10  76.2  4.10 
37  43.5  1.92, 2.35  43.4  1.92, 2.36 
38  112.5    c   
39  42.7  2.24, 2.24  42.7  2.22, 2.22 
40  71.7  4.00  71.7  3.98 
41  79.0  3.63  79.1  3.63 
42  25.6  2.23  25.4  2.23 
42-Me  17.6  0.94  17.5  0.94 
43  36.6  1.29, 1.52  36.2  1.35, 1.47 
44  97.5    c   
45  36.9  1.42, 1.50  36.1  1.37, 1.58 
46  25.7  2.35  25.5  2.43 
46-Me  17.8  0.99  17.2  1.06 
47  80.2  3.61  81.0  4.21 
48  71.7  4.05  68.8  4.26 
49  35.9  1.9, 2.32  38.6  2.50, 2.66 
50  79.8  4.08  c   
51  73.0  3.80     
52  37.2  1.62, 1.79     
53  70.4  4.02     
54   66.9   3.54, 3.61         
 
a Values in ppm relative to CHCl3 (δ 7.25) and CDCl3 (δ 77.0). b Values obtained from HSQC spectrum. c Values not detected. 
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ppm1.52.02.53.03.54.04.55.0  
Figure 3.3.1  The 1H NMR spectrum of SH3 116.2 (3.13) 
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Figure 3.3.2  The HSQC NMR spectrum of SH3 116.2 (3.13) 
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Figure 3.3.3  gCOSY, TOCSY and selected ROESY correlations for the C44-C50 region of SH3 116.2 
(3.13) 
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Figure 3.3.4  The gCOSY NMR spectrum of SH3 116.2 (3.13), showing selected correlations 
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Figure 3.3.5  The TOCSY NMR spectrum of SH3 116.2 (3.13) 
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Figure 3.3.6  The ROESY NMR spectrum of SH3 116.2 (3.13) 
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3.4  Structure elucidation of SH3 116.4 (3.14) 
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SH3 116.4 (3.14) was the second least polar of the five new halichondrin derivatives 
(Fig. 3.3.1).  High-resolution LCMS (m/z 1179.5001 [M+K]+, Δ = -6.1 mmu), in 
combination with NMR data (Table 3.4.1), gave the molecular formula C61H85ClO18 (19 
double bond equivalents).  This is 18 mass units more than that observed for 
homohalichondrin B (3.4), corresponding to the replacement of the terminal (C55) 
hydroxyl group in homohalichondrin B with chlorine.  The presence of chlorine in a 
molecule from the halichondrin family is unprecedented to date.  The NMR assignments 
were confirmed by gCOSY, TOCSY, ROESY, HSQC and CIGAR85 2D experiments, in 
addition to comparisons with the known NMR shifts for homohalichondrin B.  The 1H 
NMR spectrum is shown in Figure 3.4.1.  Due to the small sample size, no 13C NMR 
spectrum was obtained.  The 13C data reported in Table 3.4.1 were obtained from the 
HSQC and CIGAR (Fig. 3.4.2) experiments.  The CIGAR experiment was primarily 
used to obtain the 13C NMR chemical shift for position 26, and to confirm the 13C NMR 
chemical shifts around the methyl groups, using the typically prominent 2JCH and 3JCH 
correlations observed. 
As the chemical shifts on the right hand side of SH3 116.4 were very similar to those of 
SH3 116.2, the HSQC for SH3 116.4 was printed with the same scale as that of SH3 
116.2, copied onto a transparency, and overlaid.  This proved to be a very efficient 
means of establishing the known portion of the molecule, the parts of the molecule 
where change was beginning to occur, and the parts of the molecule which were in 
totally different steric and electronic environments to those of the known halichondrin.  
Once the similarity to homohalichondrin B (3.4) was established, these HSQC spectra 
were also overlaid, revealing that only positions 53-55 varied between the two 
molecules (Fig. 3.4.3). 
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Table 3.4.1  1H and 13C NMR chemical shift data for homohalichondrin B (3.4) and SH3 116.4 (3.14)a 
    homohalichondrin B   SH3 116.4 
position   C   H   Cb   H 
1  171.2    c   
2  40.4  2.34, 2.58  40.3  2.35, 2.58 
3  73.6  3.88  73.6  3.87 
4  30.7  1.34, 1.72  30.7  1.36, 1.74 
5  30.0  1.38, 2.08  29.9  1.37, 2.08 
6  68.2  4.34  68.2  4.32 
7  77.7  2.94  77.6  2.93 
8  74.3  4.32  74.3  4.32 
9  73.8  4.04  73.8  4.05 
10  76.5  4.20  76.5  4.18 
11  82.1  4.58  82.1  4.58 
12  81.1  4.68  81.2  4.67 
13  48.3  1.94, 2.16  48.3  1.94, 2.13 
14  110.1    c   
15  34.4  1.60, 2.16  34.4  1.62, 2.15 
16  28.1  1.40, 2.16  28.1  1.40, 2.17 
17  75.4  4.10  75.3  4.09 
18  38.7  2.26, 2.79  38.7  2.25, 2.79 
19  151.8    c   
19=CH2  104.5  4.91, 4.98  c  4.91, 4.98 
20  75.0  4.38  75.3  4.36 
21  29.0  1.44, 1.88  29.4  1.42, 1.89 
22  32.0  1.60, 1.60  32.0  1.60, 1.60 
23  74.8  3.52  74.8  3.53 
24  43.4  1.05, 1.70  43.2  1.05, 1.68 
25  35.9  2.20  35.9  2.20 
25-Me  18.0  1.06  18.0  1.06 
26  151.5    151.7   
26=CH2  104.2  4.75, 4.80  c  4.75, 4.80 
27  73.5  3.54  73.6  3.53 
28  36.9  1.94, 2.02  36.9  1.92, 2.00 
29  71.2  4.20  71.3  4.18 
30  76.6  4.65  76.9  4.64 
31  36.8  2.04  36.3  2.04 
31-Me  15.0  0.99  15.0  0.98 
32  77.5  3.17  77.5  3.17 
33  66.5  3.78  66.4  3.79 
34  29.4  1.80, 2.14  29.1  1.79, 2.13 
35  75.3  4.10  75.3  4.09 
36  76.3  4.10  76.3  4.10 
37  43.4  1.90, 2.35  43.5  1.91, 2.35 
38  112.4    c   
39  42.5  2.21, 2.21  42.6  2.19, 2.19 
40  70.8  3.92  70.8  3.92 
41  79.4  3.60  79.5  3.58 
42  25.8  2.32  25.7  2.32 
42-Me  17.7  0.93  17.6  0.92 
43  36.5  1.29,1.45  36.9  1.33, 1.45 
44  96.6    c   
45  36.8  1.42, 1.42  36.9  1.44, 1.44 
46  28.9  2.18  28.7  2.18 
46-Me  17.1  0.90  17.1  0.90 
47  72.8  3.06  72.8  3.06 
48  63.6  3.53  63.6  3.53 
49  31.4  1.79, 2.15  31.4  1.79, 2.19 
50  74.7  3.90  74.7  3.90 
51  76.3  4.04  76.4  4.06 
52  37.2  2.02, 2.02  37.9  2.02, 2.02 
53  79.8  4.25  77.3  4.38 
54  72.0  3.57  72.6  3.66 
55   65.6   3.69, 3.69   45.9   3.55, 3.55 
 
a Values in ppm relative to CHCl3 (δ 7.25) and CDCl3 (δ 77.0). b Values obtained from HSQC and CIGAR spectra. c Values not 
detected. 
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ppm1.52.02.53.03.54.04.55.0  
Figure 3.4.1  The 1H NMR spectrum of SH3 116.4 (3.14) 
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Figure 3.4.2  Part of the CIGAR NMR spectrum of SH3 116.4 (3.14) 
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Figure 3.4.3  The overlaid HSQC NMR spectra for SH3 116.4 (3.14) and homohalichondrin B (3.4).  
Correlations in red are those observed for SH3 116.4 only, correlations in blue are those observed for 
homohalichondrin B only, and uncoloured correlations are identical for both molecules. 
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Figure 3.4.4  Observed (A. & B.) and predicted (C. & D.) isotope patterns for SH3 116.4 (3.14) [M + 
NH4]+ and [M + NH4 –HCl]+, respectively 
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Figure 3.4.5  gCOSY and TOCSY for the C50-C55 region and selected ROESY correlations for the C47-
C55 region of SH3 116.4 (3.14) 
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3.5  Structure elucidation of SH3 118.2 (3.15) 
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SH3 118.2 (3.15) was the most polar of the five new halichondrin derivatives (Fig. 
3.3.1).  High-resolution LCMS (m/z 1099.5171 [M+Na]+, Δ = -7.1 mmu), in 
combination with NMR data (Table 3.5.1), gave the molecular formula C59H80O18 (20 
double bond equivalents).  This is 46 mass units less than that observed for 
homohalichondrin B (3.4), corresponding to the replacement of the terminal chain from 
carbon 54 in homohalichondrin B with a carboxyl moiety, thus converting the terminal 
ring to a γ-lactone.  The NMR assignments were confirmed by gCOSY, TOCSY, 
ROESY, HSQC and CIGAR 2D experiments, in addition to comparisons with the 
known NMR shifts for homohalichondrin B.  Due to the small sample size, no 13C NMR 
spectrum was run.  The 13C data reported in Table 3.5.1 were obtained from the HSQC 
and CIGAR experiments.  The 1H NMR spectrum is shown in Figure 3.5.1. 
Overlaying of the HSQC spectra with those of known halichondrins was again used to 
good effect in the structure elucidation of this molecule.  The observed 1H and 13C NMR 
shifts for SH3 118.2 (3.15) showed excellent agreement with those of homohalichondrin 
B (3.4) up to position 46, and similar shifts for position 47 (Table 3.5.1).  The 13C NMR 
chemical shift for C47 (δ 73.2) was confirmed from the CIGAR experiment, leading to 
confirmation of the 1H NMR chemical shift (δ 3.13) via the HSQC spectrum.  This left 
three methines and two methylenes unassigned from the HSQC spectrum.  The 
connectivity of this portion of the molecule was established via gCOSY and TOCSY 
data (Fig. 3.5.2).  As was observed for C49 in SH3 116.2 (3.13), a large geminal 
coupling constant of 17 Hz for the methylene protons at C52 (δ 2.56, 2.65) is consistent 
with the attachment of a carboxyl moiety at C53. 
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Table 3.5.1  1H and 13C NMR chemical shift data for homohalichondrin B (3.4) and SH3 118.2 (3.15)a 
    homohalichondrin B   SH3 118.2 
position   C   H   Cb   H 
1  171.2    c   
2  40.4  2.34, 2.58  40.3  2.32, 2.57 
3  73.6  3.88  73.7  3.87 
4  30.7  1.34, 1.72  30.6  1.37, 1.73 
5  30.0  1.38, 2.08  29.9  1.37, 2.07 
6  68.2  4.34  68.2  4.30 
7  77.7  2.94  77.7  2.92 
8  74.3  4.32  74.4  4.30 
9  73.8  4.04  73.8  4.03 
10  76.5  4.20  76.5  4.17 
11  82.1  4.58  82.2  4.57 
12  81.1  4.68  81.1  4.66 
13  48.3  1.94, 2.16  48.3  1.93, 2.14 
14  110.1    c   
15  34.4  1.60, 2.16  34.4  1.61, 2.15 
16  28.1  1.40, 2.16  28.1  1.41, 2.15 
17  75.4  4.10  75.2  4.09 
18  38.7  2.26, 2.79  38.6  2.26, 2.78 
19  151.8    c   
19=CH2  104.5  4.91, 4.98  c  4.90, 4.97 
20  75.0  4.38  75.3  4.37 
21  29.0  1.44, 1.88  29.5  1.39, 1.88 
22  32.0  1.60, 1.60  31.9  1.59, 1.59 
23  74.8  3.52  74.7  3.52 
24  43.4  1.05, 1.70  43.3  1.04, 1.67 
25  35.9  2.20  35.9  2.19 
25-Me  18.0  1.06  17.9  1.05 
26  151.5    151.7   
26=CH2  104.2  4.75, 4.80  c  4.74, 4.79 
27  73.5  3.54  73.6  3.50 
28  36.9  1.94, 2.02  36.8  1.92, 2.02 
29  71.2  4.20  71.3  4.19 
30  76.6  4.65  77.0  4.65 
31  36.8  2.04  36.3  2.01 
31-Me  15.0  0.99  15.0  0.97 
32  77.5  3.17  77.4  3.15 
33  66.5  3.78  66.3  3.78 
34  29.4  1.80, 2.14  29.1  1.77, 2.14 
35  75.3  4.10  75.2  4.09 
36  76.3  4.10  76.3  4.10 
37  43.4  1.90, 2.35  43.4  1.88, 2.34 
38  112.4    c   
39  42.5  2.21, 2.21  42.6  2.18, 2.18 
40  70.8  3.92  70.9  3.89 
41  79.4  3.60  79.3  3.57 
42  25.8  2.32  25.6  2.26 
42-Me  17.7  0.93  17.5  0.90 
43  36.5  1.29,1.45  36.6  1.32-1.40 
44  96.6    c   
45  36.8  1.42, 1.42  36.6  1.32-1.40 
46  28.9  2.18  28.6  2.17 
46-Me  17.1  0.90  16.9  0.88 
47  72.8  3.06  73.2  3.13 
48  63.6  3.53  62.7  3.59 
49  31.4  1.79, 2.15  29.9  1.91, 2.37 
50  74.7  3.90  75.2  4.31 
51  76.3  4.04  72.8  4.18 
52  37.2  2.02, 2.02  38.6  2.56, 2.65 
53  79.8  4.25  c   
54  72.0  3.57     
55   65.6   3.69, 3.69         
 
a Values in ppm relative to CHCl3 (δ 7.25) and CDCl3 (δ 77.0). b Values obtained from HSQC and CIGAR spectra. c Values not 
detected. 
Chapter 3.  New Halichondrins  64 
ppm1.52.02.53.03.54.04.55.0  
Figure 3.5.1  The 1H NMR spectrum of SH3 118.2 (3.15) 
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Figure 3.5.2  gCOSY, TOCSY and selected ROESY correlations for the C47-C52 region of SH3 118.2 
(3.15) 
 
Unfortunately, H51 (δ 4.18) was very close to H10 (δ 4.17) in the 1H NMR spectrum, so 
it was not possible to confirm cis relative stereochemistry from the observance of a 
small coupling constant as was the case for SH3 116.2 (3.13).  However, observed 
ROESY correlations (Fig. 3.5.2) indicated stereochemistry as shown above (3.15), 
which is consistent with that observed for homohalichondrin B (3.2). 
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3.6  Structure elucidation of SH3 118.3 (3.16) 
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SH3 118.3 (3.16) was the third least polar of the five new halichondrin derivatives (Fig. 
3.3.1).  High-resolution LCMS (m/z 1115.5530 [M+Na]+, Δ = -2.5 mmu), in 
combination with NMR data (Table 3.6.1), gave the molecular formula C60H84O18 (19 
double bond equivalents).  This is 30 mass units less than that observed for 
isohomohalichondrin B (3.3), corresponding to the loss of CH2O from the side chain 
from carbon 55.  The NMR assignments were confirmed by gCOSY, TOCSY, ROESY 
and HSQC 2D experiments, in addition to comparisons with the known NMR shifts for 
isohomohalichondrin B.  Due to the small sample size, no 13C NMR spectrum was 
obtained.  The 13C data reported in Table 3.6.1 were obtained from the HSQC 
experiment.  The 1H NMR spectrum is shown in Figure 3.6.1. 
Again, overlaying of the HSQC spectra with those of known halichondrins was used in 
the structure elucidation of this molecule.  The observed 1H and 13C NMR shifts for 
SH3 118.3 (3.16) showed excellent agreement with those of isohomohalichondrin B 
(3.3) up to position 50, and had similar chemical shifts at position 51 (Table 3.5.1).  
This left one methyl and one methylene unassigned from the HSQC spectrum.  The 
connectivity of this portion of the molecule was established via gCOSY and TOCSY 
data, and the relative stereochemistry was confirmed to be the same as that observed for 
isohomohalichondrin B via ROESY correlations (Fig. 3.6.2). 
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Table 3.6.1  1H and 13C NMR chemical shift data for isohomohalichondrin B (3.3) and SH3 118.3 (3.16)a 
    isohomohalichondrin B   SH3 118.3 
position   C   H   Cb   H 
1  171.1    c   
2  40.4  2.36, 2.61  40.4  2.34, 2.59 
3  73.6  3.89  73.6  3.87 
4  30.6  1.38, 1.75  30.6  1.36, 1.74 
5  30.0  1.41, 2.12  30.0  1.37, 2.08 
6  68.2  4.35  68.2  4.32 
7  77.6  2.95  77.6  2.93 
8  74.3  4.33  74.3  4.31 
9  73.8  4.06  73.8  4.04 
10  76.5  4.22  76.5  4.18 
11  82.1  4.60  82.2  4.58 
12  81.0  4.70  81.1  4.66 
13  48.3  1.95, 2.16  48.3  1.94, 2.15 
14  110.0    c   
15  34.4  1.62, 2.18  34.4  1.61, 2.18 
16  28.1  1.42, 2.18  28.0  1.42, 2.15 
17  75.3  4.10  75.3  4.09 
18  38.7  2.27, 2.80  38.7  2.25, 2.78 
19  151.7    c   
19=CH2  104.4  4.93, 5.01  c  4.91, 4.98 
20  75.3  4.39  75.3  4.36 
21  29.3  1.42, 1.90  29.4  1.39, 1.86 
22  32.0  1.62, 1.62  32.0  1.60, 1.60 
23  74.8  3.55  74.8  3.53 
24  43.3  1.05, 1.72  43.3  1.04, 1.70 
25  35.9  2.23  35.9  2.21 
25-Me  18.0  1.07  17.9  1.06 
26  151.5    c   
26=CH2  104.1  4.78, 4.83  c  4.76, 4.80 
27  73.5  3.56  73.6  3.53 
28  36.9  1.95, 2.01  36.8  1.92, 2.01 
29  71.1  4.22  71.2  4.19 
30  77.2  4.66  76.9  4.64 
31  36.5  2.03  36.5  2.02 
31-Me  15.0  1.00  15.0  0.99 
32  77.5  3.20  77.4  3.17 
33  66.4  3.84  66.3  3.80 
34  29.0  1.81, 2.16  29.0  1.80, 2.13 
35  75.1  4.12  75.3  4.09 
36  76.2  4.12  76.2  4.09 
37  43.3  1.92, 2.37  43.5  1.90, 2.33 
38  112.4    c   
39  42.5  2.22, 2.22  42.6  2.21, 2.21 
40  71.2  3.94  71.1  3.91 
41  79.0  3.64  79.1  3.61 
42  25.7  2.29  25.7  2.28 
42-Me  17.5  0.95  17.5  0.93 
43  36.9  1.33, 1.55  36.9  1.33, 1.52 
44  97.2    c   
45  37.2  1.49, 1.52  37.1  1.43, 1.48 
46  28.6  2.18  28.6  2.15 
46-Me  16.8  0.90  16.8  0.89 
47  75.9  3.25  76.0  3.22 
48  66.4  3.75  66.4  3.72 
49  34.4  1.84, 2.13  34.4  1.83, 2.10 
50  66.4  3.52  66.4  3.49 
51  76.4  3.82  76.3  3.77 
52  45.2  2.62, 2.93  45.7  2.59, 2.72 
53  209.5    c   
54  46.1  2.74, 2.74  31.1  2.18 
55   57.8   3.86, 3.86         
 
a Values in ppm relative to CHCl3 (δ 7.25) and CDCl3 (δ 77.0). b Values obtained from HSQC spectrum. c Values not detected. 
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ppm1.52.02.53.03.54.04.55.0  
Figure 3.6.1  The 1H NMR spectrum of SH3 118.3 (3.16) 
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Figure 3.6.2  gCOSY, TOCSY correlations for the C47-C54 region and selected ROESY correlations for 
the C46-C54 region of SH3 118.3 (3.16) 
Chapter 3.  New Halichondrins  68 
3.7  Structure elucidation of SH3 118.4 (3.17) 
The structure of SH3 118.4 has not yet been determined.  SH3 118.4 (3.17) was the least 
polar of the five new halichondrin derivatives (Fig. 3.3.1).  High-resolution LCMS gave 
the most likely molecular formulae as C61H86O18 (19 double bond equivalents) or 
C60H82O19 (20 double bond equivalents).  gCOSY, TOCSY, ROESY, HSQC and 
CIGAR 2D NMR experiments were run.  Due to the small sample size, no 13C NMR 
spectrum was obtained.  The 13C data reported in Table 3.7.1 were obtained from the 
HSQC and CIGAR experiments.  The 1H NMR spectrum is shown in Figure 3.7.1. 
The NMR data indicated a similarity to halichondrin B (3.2) up to C48 (Table 3.7.1), 
however the connectivity of the molecule beyond this position has yet to be established. 
 
ppm1.52.02.53.03.54.04.55.0  
Figure 3.7.1  The 1H NMR spectrum of SH3 118.4 (3.17) 
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Table 3.7.1  1H and 13C NMR chemical shift data for halichondrin B (3.2) & SH3 118.4 (3.17) up to C48a 
    halichondrin B   SH3 118.4 
position   C   H   Cb   H 
1  171.2    c   
2  40.4  2.35, 2.60  40.4  2.33, 2.59 
3  73.7  3.86  73.8  3.88 
4  30.7  1.37, 1.75  30.7  1.37, 1.72 
5  30.0  1.35, 2.08  30.0  1.35, 2.09 
6  68.2  4.34  68.2  4.32 
7  77.7  2.94  77.7  2.94 
8  74.3  4.33  74.3  4.32 
9  73.8  4.04  73.8  4.04 
10  76.5  4.20  76.5  4.19 
11  82.1  4.60  82.2  4.59 
12  81.1  4.68  81.0  4.68 
13  48.3  1.94, 2.15  48.4  1.95, 2.14 
14  110.1    c   
15  34.4  1.62, 2.18  34.5  1.57, 2.16 
16  28.2  1.42, 2.16  28.2  1.42, 2.16 
17  75.5  4.10  75.4  4.10 
18  38.7  2.26, 2.80  38.6  2.25, 2.79 
19  151.8    c   
19=CH2  104.4  4.92, 4.98  c  4.91, 4.99 
20  75.4  4.37  75.4  4.37 
21  29.5  1.40, 1.88  29.6  1.40, 1.87 
22  32.0  1.60, 1.60  32.0  1.60, 1.60 
23  74.9  3.53  74.9  3.54 
24  43.4  1.04, 1.70  43.4  1.04, 1.67 
25  35.9  2.20  36.0  2.20 
25-Me  18.0  1.07  18.0  1.06 
26  151.6    151.7   
26=CH2  104.2  4.77, 4.81  c  4.76, 4.81 
27  73.5  3.54  73.6  3.52 
28  36.9  1.94, 2.02  36.8  1.92, 2.00 
29  71.2  4.21  71.2  4.19 
30  76.9  4.63  77.0  4.65 
31  36.6  2.04  36.3  2.04 
31-Me  15.1  0.99  15.0  0.99 
32  77.5  3.18  77.5  3.18 
33  66.3  3.80  66.5  3.80 
34  29.1  1.79, 2.13  29.0  1.78, 2.13 
35  75.0  4.10  75.1  4.10 
36  76.2  4.10  76.3  4.10 
37  43.5  1.92, 2.35  43.5  1.92, 2.35 
38  112.5    c   
39  42.7  2.24, 2.24  42.7  2.22, 2.22 
40  71.7  4.00  71.3  3.98 
41  79.0  3.63  79.2  3.59 
42  25.6  2.23  25.7  2.24 
42-Me  17.6  0.94  17.6  0.94 
43  36.6  1.29, 1.52  36.8  1.29, 1.45 
44  97.5    c   
45  36.9  1.42, 1.50  37.0  1.39, 1.48 
46  25.7  2.35  25.4  2.36 
46-Me  17.8  0.99  17.7  0.99 
47  80.2  3.61  80.2  3.51 
48  71.7  4.05  71.8  4.02 
49  35.9  1.9, 2.32     
50  79.8  4.08     
51  73.0  3.80     
52  37.2  1.62, 1.79     
53  70.4  4.02     
54   66.9   3.54, 3.61         
 
a Values in ppm relative to CHCl3 (δ 7.25) and CDCl3 (δ 77.0). b Values obtained from HSQC spectrum. c Values not detected. 
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3.8  Summary 
The structures of four new halichondrins have been determined.  All of these 
compounds are very similar to known B series halichondrins, with differences occurring 
only beyond carbon 48.  As biological activity has been shown to be derived from the 
region of the molecule between carbons 1 and 30, they all retain good activity in the 
P388 assay as expected. 
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CHAPTER 4.  Marine siderophores. 
 
4.1  Introduction 
Most micro-organisms require iron for growth,86 yet iron is present at very low 
concentrations (0.02 – 1 nM) throughout much of the world’s surface ocean waters.65,87  
These low levels of iron have been shown to limit the growth of many micro-
organisms.88  In order to acquire iron, many aerobic bacteria produce siderophores, 
which are high-affinity iron(III)-binding ligands that facilitate Fe(III) transport into the 
bacterium.89  While the structures of hundreds of terrestrial siderophores are known, 
relatively few structures of siderophores produced by marine bacteria have been 
elucidated.65  A number of siderophores containing the 2,3-dihydroxybenzoate moiety, 
which functions in Fe(III) coordination, have been reported.  However, until the recent 
discovery of petrobactin (4.1),67,68 no examples with 3,4-dihydroxy substitution had 
been published.  In contrast to a plethora of reported aliphatic sulfonates,90 sulfonation 
of the aromatic groups is also rare in the natural product literature.  The known 
sulfonated aromatic natural products are siderophores derived from either a terrestrial 
Pseudomonad,91,92 or a marine Psuedoalteromonad69 species (e.g. 1.20). 
Crude oil is one of the most significant organic pollutants in the marine environment.  
Many compounds in crude oil are, however, biodegradable, and this observation has led 
to the study of oil-degrading marine micro-organisms.  Marinobacter 
hydrocarbonoclasticus, initially isolated from an oil slick on the French Mediterranean 
coast,93,94 is an ubiquitous marine bacterium95,96 that grows on a variety of hydrocarbons 
as its sole carbon source. 
In this section of work, the structural characterisation of a new siderophore, petrobactin 
sulfonate (4.2),97 isolated from the oil-degrading marine bacterium Marinobacter 
hydrocarbonoclasticus will be presented.  Petrobactin sulfonate is, to our knowledge, 
the first marine-derived siderophore containing a sulfonated 3,4-dihydroxy aromatic 
ring.  In addition, a revision of the NMR assignments of petrobactin will be discussed, 
along with the structural characterisation of the cyclic imide of petrobactin (4.3) and the 
two cyclic imides of petrobactin sulfonate (4.4 and 4.5).  These compounds are 
summarised in Table 4.1.1. 
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Table 4.1.1  Molecular formulae and calculated masses of compounds 4.1 - 4.5 
Compound Number Molecular formula Calc. [M + H]+ 
petrobactin 4.1 C34H50N6O11 719.3616 
petrobactin sulfonate 4.2 C34H50N6O14S 799.3184 
petrobactin cyclic imide 4.3 C34H48N6O10 701.3510 
petrobactin sulfonate cyclic imides 4.4 / 4.5 C34H48N6O13S 781.3078 
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4.2  Isolation and characterisation of petrobactin sulfonate (4.2) 
The siderophores produced in the culture of Marinobacter hydrocarbonoclasticus were 
isolated by adsorption to Amberlite XAD-2 resin after acidifying the culture medium to 
pH 2.5-3 and removing the bacterial cells by centrifugation.  Elution from the resin was 
achieved using 100% methanol.  Preparative-scale reversed-phase HPLC of this 
methanol fraction resulted in the isolation of the known petrobactin (4.1)67,68 and the 
new compound petrobactin sulfonate (4.2),97 with typical yields of 1.2 mg and 0.55 mg 
per litre of culture medium, respectively.  This culture and isolation work was done by 
Frithjof Küpper, a Post Doctoral research fellow in the Butler group at UCSB. 
High resolution electrospray mass spectrometry (m/z 799.3199 [M + H]+, Δ = +1.5 
mmu), in combination with 1H and 13C NMR data (Table 4.2.1, and Figures 4.2.1 and 
4.2.2, respectively), gave the molecular formula C34H50N6O14S (13 double bond 
equivalents).  The presence of sulfur was confirmed by elemental analysis.  More 
significantly, a mass difference of 80 Da from the [M + H]+ molecular ion of 
petrobactin (HRFABMS m/z 719.3614)67 suggested the addition of a sulfonate group.  
Further evidence supporting the presence of a sulfonate group was obtained from 
tandem ESI-MS in negative ion mode, considering the species at m/z 797.2.  At a 
collision voltage of > 150 V, a peak of m/z 79.9, attributable to a sulfonate moiety, was 
observed. 
The 1H and 13C NMR assignments for petrobactin sulfonate (4.2) were confirmed by 
gCOSY (Fig. 4.2.3), HSQC (Fig. 4.2.4), gHMBC (Fig. 4.2.5) and CIGAR (Fig. 4.2.6) 
2D experiments (Table 4.2.1).  The splitting patterns observed in the aromatic region of 
the 1H NMR spectrum were indicative of the unusual 3,4-dihydroxybenzoyl moiety, a 
functionality unique to petrobactin (4.1) and petrobactin sulfonate (4.2) in the marine 
siderophore literature.  The presence of a single correlation for one of the aromatic rings 
in the gCOSY experiment, from H5 (d 6.76) to H6 (d 7.18), also supported 3,4-
disubstitution.  It was not possible to see the equivalent correlation from the other 
aromatic ring in this experiment, due to the closeness in chemical shift of the H5' (d 
6.76) and H6' (d 6.72) protons.  All correlations observed in the gHMBC and CIGAR 
experiments in the aromatic region were consistent with the presence of two catechol 
rings, including two 4JCH correlations, from H6 (d 7.18) to C3 (d 144.9) and H6' (d 6.72) 
to C3' (d 142.3), in the CIGAR experiment.  No evidence to differentiate the hydroxyl 
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protons at the 3, 4 and 4' positions was obtained (d 9.12, 9.16 and 9.54, respectively), 
however the 3'-OH proton was able to be assigned at 11.23 ppm, due to observed 
correlations in the gHMBC and CIGAR experiments to C2' (d 127.0), C3' (d 142.3) and 
C4' (d 147.2). 
Figure 4.2.1  The 1H NMR spectrum of petrobactin sulfonate (4.2) 
Figure 4.2.2  The 13C NMR spectrum of petrobactin sulfonate (4.2) 
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Table 4.2.1  1H, 13C and 2D NMR data for Petrobactin sulfonate (4.2)a 
position δH mult (J in Hz) δC gCOSY HSQC gHMBC and CIGARb 
1 na 125.4    
1' na 126.6    
2 7.27 d (2)  115.0  C2 C1 (wk), C3, C4, C6, C7 
2' na 127.0    
3 na 144.9    
3' na 142.3    
4 na 148.5    
4' na 147.2    
5 6.76 d (8.5)  114.8 H6 C5 C1, C2 (wk),c C3, C4, C7 
5' 6.76 d (8.5) 115.5  C5' C1', C3', C4', C7' c 
6 7.18 dd (2, 8.5)  119.0 H5 C6 C2, C3 (wk),c C4 (wk),c C7 
6' 6.72 d (8.5) 119.6  C6' C2', C3', C4', C7' 
7 na 166.6    
7' na 169.3    
8 / 8' 3.27 m 36.1, 36.2 H9/H9', N1H/N1'H C8 / C8' C7/C7', C9/C9', C10/C10' 
9 1.80 m 26.3 H8, H10 C9 C8, C10 
9' 1.80 m 25.6 H8', H10' C9' C8', C10' 
10 2.89 m 44.8 H9, N2H C10 C8 (wk)c 
10' 3.12 m 44.4 H9', N2'H C10' C8',c C9'd 
11 / 11' 2.89 m 46.5 H12/H12', N2H/N2'H C11/C11' C13/C13' (wk)c 
12 / 12' 1.56 m 23.0 H11/H11', H13/H13' C12/C12' C11/C11',d C13/C13',d C14/C14' (wk)  
13 / 13' 1.43 m 26.0 H12/H12',H14/H14' C13/C13' C11/C11', C12/C12',d C14/C14' 
14 / 14' 3.04 m 37.7 H13/H13', N3H/N3'H C14/C14' C12/C12', C13/C13', C15/C15' 
15 / 15' na 169.5    
16 / 16' 
 
2.50 d (15), 2.58 d (15), 
2.59 d (14.5) 
43.3 
  
C16/C16' 
 
C15/C15', C16'/C16, C17, C18 
 
17 na 73.5    
18 na 175.0    
N1H 8.31 t (6) na H8  C7, C8 
N1'H 8.19 t (6) na H8'  C7', C8' 
N2H 8.27 m na H10, H11   
N2'H 8.23 m na H10', H11'   
N3H/N3'H 7.99 t (5) na H14/H14'  C14/C14', C15/C15' 
OH (C3') 11.23 s na   C2', C3', C4' 
OH (C3 / 
C4 / C4')  
9.12, 9.16, 9.54 
(all br s)     
a Values in ppm relative to CD3(CHD2)SO (δ 2.50) and (CD3)2SO (δ 39.6).  b gHMBC and CIGAR experiments run with coupling 
constants optimised at 5 and 5-10 Hz, respectively.  c Correlation only seen in the CIGAR experiment.  d Weak correlation observed 
in the CIGAR experiment. 
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The aromatic splitting patterns in the 1H NMR spectrum also indicated that the sulfonate 
group was attached to one of the catechol rings of the previously symmetrical 
petrobactin molecule.  The H2 doublet (δ 7.27), H5 doublet (δ 6.76) and H6 doublet of 
doublets (δ 7.18) remained from the 1H NMR spectrum of petrobactin, however these 
resonances integrated as one proton, two protons and one proton, respectively.  Thus, 
the doublet at 6.76 ppm accounted for both H5 and H5'.  The doublet of doublets at 7.18 
ppm, assigned to H6 and due to the combination of H5 vicinal (ortho) coupling (8.5 Hz) 
and H2 meta coupling (2 Hz), was not seen for H6'.  Instead, a 1-proton doublet, with 
H5' ortho coupling only (8.5 Hz), was observed for this proton (δ 6.72).  The lack of 
meta coupling in this signal indicated substitution at the 2' position.  In addition, no 
signal assignable to a proton attached to C2' was observed.  Thus, it was inferred that 
the sulfonate was in the 2' position. 
The connectivity of the molecule was determined via gCOSY (Fig. 4.2.3), gHMBC 
(Fig. 4.2.5) and CIGAR (Fig. 4.2.6) correlations (Table 4.2.1).  The gCOSY experiment 
unequivocally established the connectivity of the two spermidinyl moieties in the 
molecule.  In particular, gCOSY correlations from H11 (d 2.89) and H13 (d 1.43) to 
H12 (d 1.56) and from H12 and H14 (d 3.04) to H13 (along with the equivalent 
correlations to H12' and H13') required a reversal of the 1H and 13C assignments at the 
12 and 13 positions from those previously reported for petrobactin (4.1).67,68 
The attachment of each catechol ring to a spermidinyl group via a carbonyl group on 
both sides of the molecule was established through gHMBC and CIGAR correlations 
(Table 4.2.1, and Figures 4.2.5 and 4.2.6, respectively), including two 4JCH correlations, 
from H5 (d 6.76) to C7 (d 166.6) and H5' (d 6.76) to C7' (d 169.3), in the CIGAR 
experiment.  These experiments also established the connectivity of the N3 / N3' ends of 
the spermidinyl groups to a single citryl moiety, as well as the connectivity of the citryl 
group itself. 
It appears that the structure of petrobactin sulfonate (4.2) is in the form of a double 
zwitterion involving N2 and N2' and the sulfonate and carboxylate moieties.  The 
strongest evidence for this lies in the observed chemical shifts for the N2 and N2' 
protons (d 8.27 and 8.23, respectively), which are in the correct range for protons on a 
positively charged nitrogen in an alkyl chain (~ 6 – 9 ppm) and significantly downfield 
from the expected chemical shift for protons on a neutral nitrogen atom in an alkyl 
chain (0.5 – 4 ppm).98  Further evidence is to be found in the observed proton and 
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carbon chemical shifts at the adjacent 10 / 10' and 11 / 11' positions (Table 4.2.1),98,99 in 
the integrals of the protons attached to nitrogen in the 1H NMR spectrum and in the 
splitting of H10' in the same spectrum (triplet of triplets, appearing as a “quintet”). 
 
Figure 4.2.3  The gCOSY NMR spectrum of petrobactin sulfonate (4.2) 
 
 
 
Figure 4.2.4  The HSQC NMR spectrum of petrobactin sulfonate (4.2) 
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Figure 4.2.5  The gHMBC NMR spectrum of petrobactin sulfonate (4.2) 
 
 
Figure 4.2.6  The CIGAR NMR spectrum of petrobactin sulfonate (4.2) 
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4.3  Revision of the NMR assignments of petrobactin (4.1) 
In determining the structure of petrobactin sulfonate, observed gCOSY correlations 
from H11 (d 2.89) and H13 (d 1.43) to H12 (d 1.56) and from H12 and H14 (d 3.04) to 
H13 (along with the equivalent correlations to H12' and H13') required a reversal of the 
1H and 13C assignments at the 12 and 13 positions from those previously reported for 
petrobactin (4.1).67,68  In order to confirm that such a reversal should also apply in the 
case of petrobactin itself (see Fig. 4.3.1 for the 1H NMR spectrum), a gCOSY 
experiment was run on a petrobactin sample (Fig. 4.3.2).  In this experiment, 
correlations from H11 (d 2.89) and H13 (d 1.42) to H12 (d 1.55) and from H12 and H14 
(d 3.04) to H13 confirmed that the previously reported 1H and 13C assignments at 
positions 12 and 13 in this molecule did in fact need to be interchanged. 
 
Figure 4.3.1  The 1H NMR spectrum of petrobactin (4.1) 
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Figure 4.3.2  The gCOSY NMR spectrum of petrobactin (4.1) 
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4.4  The cyclic imide of petrobactin (4.3) 
It was observed that a loss of 18 mass units occurred on exposure of petrobactin to acid.  
Reaction of petrobactin with 0.1% TFA gave ~10% of the dehydrated form after an 
hour.  This compound has subsequently been established as the cyclic imide of 
petrobactin (4.3), and was isolated via preparative-scale reversed-phase HPLC.  
Analysing compound 4.3 via high-resolution ESIMS (m/z 701.3511 [M + H]+, Δ = +0.1 
mmu), in combination with NMR data (Table 4.4.1), the molecular formula 
C34H48N6O10 (14 double bond equivalents) was obtained.  This is 18 mass units less 
than that observed for petrobactin, corresponding to loss of water on formation of the 
cyclic imide.  The NMR assignments were confirmed by gCOSY, HSQC and CIGAR 
2D experiments, in addition to comparisons with the known NMR shifts for petrobactin 
and petrobactin sulfonate.  The 1H NMR spectrum is shown in Figure 4.4.1. 
 
Figure 4.4.1  1H NMR spectrum of the cyclic imide of petrobactin (4.3) 
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Table 4.4.1  1H, 13C and 2D NMR data for the cyclic imide of Petrobactin (4.3)a 
position δH mult (J in Hz) δC gCOSY HSQC CIGARb 
1 / 1' na 125.4    
2 7.27 d (2) 115.0  C2 C1, C3, C4, C6, C7 
2' 7.27 d (2) 115.0  C2' C1', C3', C4', C6', C7' 
3 / 3' na 144.9    
4 / 4' na 148.5    
5 6.76 d (8.5) 114.8 H6 C5 C1, C3, C4, C7 
5' 6.76 d (8.5) 114.8 H6' C5' C1', C3', C4', C7' 
6 7.18 dd (2, 8.5) 119.0 H5 C6 C2, C3, C4, C5, C7 
6' 7.18 dd (2, 8.5) 119.0 H5' C6' C2', C3', C4', C5', C7' 
7 / 7' na 166.7    
8 / 8' 3.27 m 36.1 H9/H9', N1H/N1'H C8/C8' C7/C7', C9/C9', C10/C10' 
9 / 9' 1.80 m 26.2 H8/H8', H10/H10' C9/C9' C8/C8', C10/C10' 
10 / 10' 2.89 m 44.8 H9/H9', N2H/N2'H C10/C10'  
11 / 11' 2.89 m 46.3, 46.5 H12/H12', N2H/N2'H C11/C11'  
12 / 12' 1.55 m 22.9, 23.1 H11/H11', H13' C12/C12' C11/C11' 
13 1.55 m 24.2 H14 C13 C11 
13' 1.39 m 26.0 H12', H14' C13' C11', C12', C14' 
14 3.38 t (6.5) 37.2 H13 C14 C12, C13, C15, C18 
14' 2.97 m 37.7 H13', N3'H C14' C12', C13', C15' 
15 na 175.1    
15' na 168.7    
16 2.53 d (15.5), 2.87 d (15.5) 42.0 H16 C16 C15, C16', C17, C18 
16' 2.65 d (15.5), 2.79 d (15.5)  H16' C16' C15', C16, C17, C18 
17 na 72.0    
18 na 178.7    
N1H 8.31 t (5) na H8  C7, C8 
N1'H 8.31 t (5) na H8'  C7', C8' 
N2H 8.38 m na H10, H11   
N2'H 8.38 m na H10', H11'   
N3'H 8.10 t (5.8) na H14'  C14', C15' 
OH (C3, C3',  
C4, C4') 
9.11, 9.55 (both br s) 
 
na 
    
 
a Values in ppm relative to CD3(CHD2)SO (δ 2.50) and (CD3)2SO (δ 39.6).  b CIGAR experiment run with coupling constants 
optimised at 5-10 Hz. 
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The observed 1H NMR shifts for the cyclic imide of petrobactin (4.3) showed excellent 
agreement with those of petrobactin up to C12 / C12'.  The connectivity of the 
remainder of the molecule was established via gCOSY and CIGAR data (Table 4.4.1).  
In the CIGAR experiment, 4JCH correlations were observed between H5 / H5' (d 6.76) 
and C7 / C7' (d 166.7), H5 / H5' (d 6.76) and C2 / C2' (d 7.27), and H6 / H6' (d 7.18) & 
C3 / C3' (d 144.9), as expected from the data discussed above for petrobactin sulfonate 
(Fig. 4.4.2).  The CIGAR experiment was also used to confirm the chemical shifts of 
C15, C15', and C18.  Correlations to C15 (d 175.1) were observed from both H14 (d 
3.38) and H16 (d 2.53, 2.87).  Correlations to C15' (d 168.4) were observed from both 
H14' (d 2.97) and H16' (d 2.65, 2.79).  And correlations to C18 (d 178.7) were observed 
from H14 (d 3.38), H16 (d 2.53, 2.87) and H16' (d 2.65, 2.79).  The correlation between 
H14 and C18 is of particular importance in corroborating the formation of the cyclic 
imide.  The 1H NMR signal for the N3' proton integrated as one proton, lending further 
support. 
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Figure 4.4.2  Selected CIGAR correlations for the cyclic imide of petrobactin (4.3) 
 
The structure of the cyclic imide of petrobactin (4.3) appears to be in the form of a 
double zwitterion, as was found for petrobactin sulfonate.  Again, evidence for this lies 
in the observed chemical shift for the N2 / N2' protons (d 8.38), a signal which 
integrates as four protons, and in the observed proton and carbon chemical shifts at the 
adjacent 10 / 10' and 11 / 11' positions (Table 4.4.1).  Unlike the situation for 
petrobactin sulfonate, however, all the H10 / H10' and H11 / H11' protons had the same 
chemical shift (d 2.89), so no further evidence for the presence of a double zwitterion 
could be extracted from splitting patterns. 
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4.5  The cyclic imides of petrobactin sulfonate (4.4 and 4.5) 
As petrobactin sulfonate is not a symmetrical molecule, exposure of this compound to 
acid resulted in the formation of two cyclic imides, compounds 4.4 and 4.5.  These 
cyclic imides were obtained by reacting petrobactin sulfonate with 0.5% formic acid for 
five days at 40 degrees Celsius (Fig. 4.5.1).  The subsequent appearance of two later-
eluting peaks was noted in the HPLC traces during this conversion (Fig. 4.5.1).  These 
were hypothesised to be the acid derivatives 4.6 and 4.7 of the cyclic imides, but were 
not investigated further. 
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Purification of the cyclic imides was achieved via preparative-scale reversed-phase 
HPLC.  Analysing a mixture of compounds 4.4 and 4.5 via high-resolution ESIMS (m/z 
781.3047 [M + H]+, Δ = -3.1 mmu), in combination with NMR data (Table 4.5.1), the 
molecular formula C34H48N6O13S (14 double bond equivalents) was obtained.  This is 
18 mass units less than that observed for petrobactin sulfonate, again corresponding to 
loss of water on formation of the cyclic imide.  The NMR assignments were confirmed 
by gCOSY, HSQC and CIGAR 2D experiments, in addition to comparisons with the 
known NMR shifts for petrobactin sulfonate.  The 1H NMR spectrum is shown in 
Figure 4.5.2.  The data presented in Table 4.5.1 are reported for compound 4.5 only for 
the purpose of clarity. 
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Figure 4.5.1  Stacked HPLC chromatograms recorded over eight days showing the conversion of 
petrobactin sulfonate (4.2) to its two cyclic imides (4.4 and 4.5), along with the subsequent conversion of 
the cyclic imides to their proposed acid derivatives (4.6 and 4.7), in the presence of acid at 40 °C. Peaks 
on the top trace are labelled. 
 
Figure 4.5.2  1H NMR spectrum of a mixture of the cyclic imides of petrobactin sulfonate (4.4 and 4.5) 
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Table 4.5.1  1H, 13C and 2D NMR data for one of the cyclic imides of Petrobactin sulfonate (4.5)a 
position δH mult (J in Hz) δC gCOSY HSQC CIGARb 
1 na 125.5    
1' na 126.7    
2 7.26 br s 115.2  C2 C3, C4, C6, C7 
2' na 127.1  C2' C1', C3', C4', C6', C7' 
3 na 145.1    
3' na 142.5    
4 na 148.6    
4' na 147.4    
5 6.76 d (8) 115.0 H6 C5 C1, C3, C4 
5' 6.76 d (8) 115.7  C5' C1', C3', C4', C7' 
6 7.17 br d (8.5) 119.1 H5 C6 C4, C5, C7 
6' 6.71 d (8) 119.8  C6' C2', C4', C7' 
7 na 166.8    
7' na 169.4c    
8 / 8' 3.26 m 36.4 H9/H9', N1H/N1'H C8/C8' C7/C7', C9/C9', C10/C10' 
9 1.76c m 26.8d  C9  
9' 1.80c m 25.9d  C9'  
10 2.87 m 45.2d H9/H9', N2H/N2'H C10  
10' 3.08 44.7d  C10' C9' 
11 / 11' 2.87 m 46.7  C11/C11'  
12 / 12' 1.54 m 23.5  C12/C12'  
13 1.54 m 24.4d  C13  
13' 1.40 m 26.3  C13'  
14 3.39 br s 37.5d  C14 C13, C15, C18 
14' 3.00 m 38.1  C14'  
15 na 175.2c    
15' na 168.7c    
16 2.52 d (15), 2.53 d (15), 2.89 d (15) 42.3d H16 C16 C15, C16', C17, C18 
16' 2.64 d (15), 2.65 d (15), 2.79 d (15.5) 42.2d H16' C16' C15', C16, C17, C18 
17 na 72.2    
18 na 179.0    
N1H 8.30 t (5) na H8  C7 
N1'H 8.17 t (5.5) na H8'  C7' 
N2H/ N2'H nd na    
N3'H 8.10 t (4) na H14'  C15' (weak) 
 
a Values in ppm relative to CD3(CHD2)SO (δ 2.50) and (CD3)2SO (δ 39.6).  b CIGAR experiment run with coupling constants 
optimised at 5-10 Hz.  c Chemical shift obtained from the CIGAR experiment.  d Chemical shift obtained from the HSQC 
experiment. 
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The observed 1H NMR shifts for the cyclic imides of petrobactin sulfonate (4.4 and 4.5) 
showed excellent agreement with those of petrobactin sulfonate up to C12 / C12'.  The 
connectivity of the remainder of the molecule was established via gCOSY and CIGAR 
data (Table 4.4.2).  Correlations in the CIGAR experiment to C15 (d 175.2) were 
observed from both H14 (d 3.39) and H16 (d 2.52, 2.53, 2.89).  Correlations to C15' (d 
168.4) were observed from H16' (d 2.64, 2.65, 2.79), while correlations to C18 (d 
178.7) were observed from H14 (d 3.39), H16 (d 2.52, 2.53, 2.89) and H16' (d 2.64, 
2.65, 2.79).  Again, the correlation between H14 and C18 is of particular importance in 
establishing the formation of the cyclic imide, and the 1H NMR signal for the N3' 
proton integrated as one proton, lending further support. 
As was the case for petrobactin sulfonate, due to the closeness in chemical shift it was 
not possible to confirm a correlation in the gCOSY experiment between the H5' (d 6.76) 
and H6' (d 6.71) protons.  Although the N1 (d 8.30), N1' (d 8.17) and N3' (d 8.10) 
protons were seen in the 1H NMR spectrum, the N2 / N2' protons were not observed, 
presumably due to their more readily exchangeable nature. 
Unfortunately, the quality of the proton and carbon spectra was not as high as that 
obtained for the other siderophores discussed above.  This was due to a smaller sample 
size and possibly also that the analysis was done on a mixture of the two cyclic imides 
of petrobactin sulfonate, creating a slight “blurring” effect.  As a result of this, some of 
the 13C NMR resonances were obtained from the HSQC and CIGAR experiments 
(Table 4.4.2).  In addition, some of the splitting patterns observed for the other 
siderophores in the 1H NMR spectra were not observed in this case.  For example, a 
broad singlet was observed for the H2 proton (d 7.26) instead of the expected doublet 
due to meta coupling across the ring, a broad doublet was observed for the H6 proton (d 
7.17) instead of the expected doublet of doublets, and a broad singlet was observed for 
the H14 proton (d 3.39) instead of the expected triplet.  This loss of detail carried over 
into the CIGAR experiment also, where only one of the previously observed 4JCH 
correlations was seen, between H5' (d 6.76) and C7' (d 166.7).  However, the data 
obtained were still of sufficient quality to unequivocally characterise the compounds. 
It is likely that these compounds are also in the form of a double zwitterion, although 
evidence for this lies solely in the observed proton and carbon chemical shifts at the 10 / 
10' and 11 / 11' positions.  As the N2 / N2' protons were not observed in the 1H NMR 
spectrum, nothing can be deduced from an observed chemical shift or an integral.  
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Although a discrete signal was observed for the H10' proton (d 3.08), downfield from 
the H10 / H11 / H11' resonances (d 2.87), the splitting pattern was not clear, so nothing 
could be inferred about the number of protons attached to the adjacent nitrogen. 
Purification of each of the petrobactin sulfonate cyclic imides was achieved via 
analytical HPLC on ODS-silica, using a CH3CN/H2O gradient (7% to 11%) over 20 
minutes, with 0.5% formic acid and a column temperature of 26 degrees Celsius.  These 
were stable for limited periods of time in the freezer, however unfortunately they re-
equilibrated to a 1:1 mixture at room temperature (Fig. 4.5.3). 
Due to the difficulty in maintaining pure samples of each of the cyclic imides of 
petrobactin sulfonate, a mixture of compounds 4.4 and 4.5 was analysed via LCMSMS 
in an attempt to distinguish them.  The same HPLC conditions described above for the 
purification of the two cyclic imides were used.  From an analysis of the fragmentation 
patterns of each peak observed in the HPLC chromatogram, it was determined that the 
first eluting peak was compound 4.4 and the second eluting peak was compound 4.5 
(Fig. 4.5.4). 
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Figure 4.5.3  Stacked HPLC chromatograms recorded over seven days showing the re-equilibration of 
one of the petrobactin sulfonate cyclic imides (4.4) to a 1:1 mixture of the two cyclic imides (4.4 and 4.5) 
at 40 °C 
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Figure 4.5.4  LCMSMS of the cyclic imides of petrobactin sulfonate (4.4 and 4.5), showing the 
fragmentation patterns that distinguished compounds 4.4 and 4.5.  The top trace is that of the first eluting 
cyclic imide (4.4) and the bottom trace that of the second eluting cyclic imide (4.5) on a C18 column 
 
It is interesting to compare the signals for the H16 / H16' protons across the five 
siderophores discussed above.  These were observed as two doublets for petrobactin, 
three doublets for petrobactin sulfonate, four doublets for the cyclic imide of 
petrobactin, and six doublets for the cyclic imides of petrobactin sulfonate.  This was 
due to a lack of symmetry in the sulfonated siderophores. 
 
4.6  Summary 
A new sulfonated siderophore, petrobactin sulfonate (4.2),97 has been isolated and 
characterised.  Interestingly, only one of the two catecholate groups of the otherwise 
symmetrical molecule was sulfonated.  This sulfonate functionality was unequivocally 
established to be vicinal to the two hydroxyl groups on one of the catecholate ring 
systems, as is the case for the sulfonated dihydropyoverdins.91  The sulfonated form of 
petrobactin is more hydrophilic than petrobactin, which results in shorter retention times 
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in RP-HPLC and probably also in reduced membrane permeability.  The altered 
physicochemical properties might also have a function in the particular environment of 
Marinobacter hydrocarbonoclasticus at the interface of seawater to oil hydrocarbons.  
In an analogous case, TRENCAM, a synthetic siderophore analogue containing the 
aromatic 2,3-dihydroxy catechol group, was rendered more water-soluble by 
sulfonation.100 
In addition, a revision of the NMR assignments of petrobactin has been presented, along 
with the structural characterisation of the cyclic imide of petrobactin (4.3) and the two 
cyclic imides of petrobactin sulfonate (4.4 and 4.5).  Compound 4.3 has been reported 
previously as an impurity in the synthesis of petrobactin.68,101  Cyclic imide formation 
has also been observed in other siderophores.102  Compounds 4.4 and 4.5 occur as a 1:1 
mixture, and re-equilibrate to this from a pure sample of each.  They were, however, 
successfully distinguished via tandem LCMS. 
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CHAPTER 5.  Experimental. 
 
5.1  General Methods 
5.1.1  Nuclear Magnetic Resonance (NMR) 
1H, COSY, TOCSY, ROESY, HSQC, HMBC and CIGAR experiments were all 
recorded on a Varian INOVA 500 spectrometer at 23°C, operating at 500 MHz.  The 
INOVA was equipped with a variable temperature and inverse-detection 5 mm probe, a 
triple-resonance indirect detection PFG probe for compounds 4.1, 4.2 and 4.3, or a 500 
MHz Protasis Capillary NMR probe for spectra reported in Chapter 3.  The 13C NMR 
spectrum on the mixture of compounds 4.4 and 4.5 was recorded on a Varian UNITY 
300 NMR spectrometer, at 23°C, operating at 75 MHz.  The UNITY was equipped with 
a variable temperature direct broadband 5 mm probe.  The 13C NMR spectra for 
compounds 4.1, 4.2 and 4.3 were recorded on a Varian INOVA 500 spectrometer at 
23°C, operating at 125 MHz, using a 5mm variable temperature switchable PFG probe.  
Chemical shifts are expressed in parts per million (ppm) on the d scale, and were 
referenced to the appropriate solvent peaks: CDCl3 referenced to CHCl3 at dH 7.25 (1H) 
and CHCl3 at dC 77.0 (13C); CD3OD referenced to CHD2OD at dH 3.31 (1H) and 
CD3OD at dC 49.3 (13C); DMSO-d6 referenced to CD3(CHD2)SO at dH 2.50 (1H) and 
(CD3)2SO at dC 39.6 (13C).  The spectra in Chapter 3 were obtained in CDCl3 with 0.1% 
C5D5N, in order to remove any traces of acid from the solvent. 
 
5.1.2  Fast Atom Bombardment Mass Spectrometry 
Low Resolution Fast Atom Bombardment Mass Spectrometry (LRFABMS) was 
recorded on a Kratos MS80 RFA Mass Spectrometer operated at 4000 V.  An Ion Tech 
ZNIIFN ion gun was used, with Xe as the reagent gas, operating at 8 kV with an ion 
current of 2 mA, and using m-nitrobenzyl alcohol (NOBA) as the support matrix. 
 
5.1.3  Liquid Chromatography Mass Spectrometry 
High Resolution Liquid Chromatography Mass Spectra (HRLCMS) were recorded on a 
Waters 2790 HPLC system equipped with a Waters 996 photodiode array detector 
(PDA) coupled to a Micromass LCT spectrometer using a probe voltage of 3200V, an 
operating temperature of 150°C and a source temperature of 80°C.  The carrier solvent 
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was 50:50 ACN/H2O at 20 µL/minute (for direct inject mode).  Typically, 10 µL of a 10 
µg/mL solution was injected.  Leucine enkephalin was used as the internal standard. 
 
5.1.4  Electrospray Ionisation Mass Spectrometry 
High Resolution Electrospray Ionisation Mass Spectra (HRESIMS) were recorded on a 
Micromass LCT spectrometer using a probe voltage of 3200V, an operating temperature 
of 150°C and a source temperature of 80°C.  The carrier solvent was 50:50 ACN/H2O at 
20 µL/minute (for direct inject mode).  Typically, 10 µL of a 10 µg/mL solution was 
injected.  Leucine enkephalin was used as the internal standard.  Electrospray–
ionization mass spectra (ESI-MS) reported in Chapter 4 were recorded in both the 
positive and negative modes on a Micromass (Manchester, UK) quadrupole time of 
flight (QTOF-2) mass spectrometer. 
 
5.1.5  Tandem Liquid Chromatography Mass Spectrometry 
Tandem Liquid Chromatography Mass Spectrometry (LCMSMS) used in the analysis 
of compounds 4.4 and 4.5 in Chapter 4 were performed on an LC ACQUITY UPLC® 
System with a Waters Quattro micro™ API mass spectrometer.  An Agilent Zorbax SB-
C18 column was used (5mm, 150 x 2.1 mm), with a 7 to 11% CH3CN/H2O gradient over 
20 minutes, with 0.5% formic acid. 
 
5.1.6  High Performance Liquid Chromatography (HPLC) 
In most projects the Milli-QÒ H2O was acidified with 0.05% TFA.  No TFA was used in 
the analyses reported in Chapter 3.  All samples were filtered through 0.45 µm PTFE 
membrane filters immediately prior to injection. 
Analytical HPLC was carried out on a Dionex liquid chromatograph equipped with a 
UVD 340U diode array detector, and connected to an Alltech ELSD 800.  For reversed 
phase HPLC, a Phenomenex Prodigy C18 ODS3 column (5 mm, 250 x 4.6 mm) was 
used, apart from analyses in Chapter 3 where a reversed phase Brownlee Labs analytical 
ODS-224 SPHERI-5 column (5 mm, 220 x 4.6 mm) was used.  A standard flow rate of 1 
mL/min was used with stated concentrations of ACN (HPLC grade) in H2O (Milli-QÒ).  
Variable concentrations of ACN or MeOH (HPLC grade) in H2O (Milli-QÒ) were used 
for the mobile phase. 
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Preparative HPLC was performed on a Shimadzu LC-4A instrument equipped with a 
UV Spectrophotometric Detector SPD-2AS (wavelength l=210 nm) and a Hewlett 
Packard 3390A integrator.  Reversed phase HPLC was performed on a Phenomenex 
Luna C18, 10 x 250 mm, 5 µ column run at 5 mL/min.  Variable concentrations of ACN 
or MeOH (HPLC grade) in H2O (Milli-QÒ) were used for the mobile phase. 
 
5.1.7  Column chromatography 
Column chromatography was performed with glass columns of stated dimensions or in 
pre-prepared cartridges as indicated.  All solvents used for chromatography were of 
commercial grade and distilled once, except for MeOH, which was double distilled.  
Reversed phase C18 columns were run under pressure (0.5 kPa) with oxygen-free N2 
gas. 
Reversed phase chromatography (RP) used Bakerbond (40mm) octadecyl (C18) 
packing.  Samples were either dissolved in a minimal volume of solvent and loaded 
directly on to the column, or absorbed to fresh C18 or celite at a ratio of 1:50 using a 
minimum volume of solvent which was removed under vacuum prior to loading onto 
the column.  Sephadex LH20 (Pharmacia Biotech AB) pre-soaked overnight in CH2Cl2 
was used for gel permeation chromatography. 
 
5.1.8  Thin Layer Chromatography (TLC) 
DIOL analytical TLC was performed using Merck F254 glass-backed plates of 0.2 mm 
thickness.  DIOL plates were eluted with 4 % MeOH/CH2Cl2.  Merck RP-18 F254 TLC 
plates of 0.2 mm thickness were used for the analytical C18 TLC, eluting with stated 
CH3CN/H2O mixtures.  TLC plates containing halichondrins were visualised using a 
phosphomolybdic acid (PMA) in ethanol (EtOH) spray (10% PMA in EtOH, w/v), 
followed by heating at ca 80 °C for 5 minutes to yield characteristic brown spots. 
 
5.1.9  Scanning Electron Microscopy (SEM) 
A Leica S440 scanning electron microscope was used, at accelerating voltages of 10-20 
kV. 
 
5.1.10  Transmission Electron Microscopy (TEM) 
A JEOL JEM 1200-EX was used, at an accelerating voltage of 80 kV. 
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5.1.11  Optical rotation 
Optical rotations were measured at 589 nm (NaD) using a Perkin-Elmer 341 polarimeter. 
 
5.1.12  P388 assay 
This assay involved the use of the murine leukaemia cell line P388 (ATCC CCL 46, 
P388D1), and consisted of a serial dilution of the sample of interest followed by 
incubation for 72 hours with P388 cells.  Cell viability was determined colorimetrically 
by the addition of a yellow dye, MTT tetrazolium.  Unhealthy or dead cells cannot 
metabolise this dye, so a yellow colour remains.  Healthy cells, however, are able to 
reduce the dye to MTT formazan, resulting in an intense purple colour (Figure 5.1.1). 
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Figure 5.1.1  Reduction of the yellow MTT tetrazolium salt to the purple MTT formazan by healthy P388 
cells 
 
The concentration of the sample required to reduce cell growth by 50%, when compared 
to a set of controls, is expressed as an IC50 in ng/mL. 
 
5.1.13  Solvents 
HPLC grade solvents, doubly deionized Nanopure water and Milli-QÒ water were used 
where stated.  Technical grade solvents were distilled prior to use.  Methanol was 
distilled twice. 
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5.2  Work Described in Chapter Two 
 
5.2.1  Calcium magnesium free artificial seawater 
Calcium magnesium free artificial seawater (CMF-ASW) was prepared by combining 
the following two solutions, and adjusting the resultant solution to pH 8.2 using NaCl 
and HCl: 
Solution 1: 27 g NaCl 
  1 g Na2SO4 
  0.8 g KCl 
  0.2 g NaHCO3 
  500 mL deionised water 
Solution 2: (0.2 M phosphate buffer) 
  2.76 g NaH2PO4 
  11.35g Na2HPO4 
  500 mL deionised water 
 
5.2.2  PercollÒ density gradient 
A bent Pasteur pipette was used to layer 2 mL of each of 60, 45, 30, 15 and finally 5 % 
PercollÒ solutions (in CMF-ASW) in a 15 mL polypropylene centrifuge tube, to make a 
10 mL PercollÒ density gradient.  The dissociated cells were loaded on to the top of the 
gradient, and centrifuged at 600 rpm for 10 minutes.  The resultant bands of cells were 
removed with a Pasteur pipette.  PercollÒ was from Sigma (P-1644, 65455-52-9). 
 
5.2.3  Fixed Lamellomorpha strongylata samples 
Six duplicate (twelve in total) samples of Lamellomorpha strongylata in fixative were 
used.  In each set of six samples, three were diced sponge pieces and three were whole 
pieces of sponge.  Fixative used were: 
a. 2.5 % glutaraldehyde 
 0.05 M cacodylate, pH 8.0 
b. 2.5 % glutaraldehyde 
 2.0 % formaldehyde 
 0.05 M cacodylate, pH 7.8 
c. 2.0 % formaldehyde 
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 0.05 M cacodylate, pH 8.0 
d. 0.2 % glutaraldehyde in CMF-ASW, pH 8.3 
 
Formaldehyde was used for fixing samples quickly, while glutaraldehyde was thought 
to be a better long-term fixative. 
 
5.2.4  Fixed Lissodendoryx sp. samples 
Samples were provided by NIWA in the following four fixatives: 
a. Davidsons: 10 % glycerine 
   20 % formalin 
   30 % 95% EtOH 
   30 % deionised water 
   10 % glacial acetic acid 
b. IG4F:  1 % glutaraldehyde 
   4 % stock buffered formaldehyde in 50 % filtered seawater 
c. 10 % formaldehyde in CMF-ASW 
d. 1.9 % formaldehyde, 1.5 % glutaraldehyde in CMF-ASW 
 
5.2.5  Gram positive / Gram negative staining 
1. Cell sample left to dry on a microscope slide, then passed through a flame. 
2. Slide covered in crystal violet, and left for 30 seconds. 
3. Slide washed with water, covered with Gram’s iodine, and left for 30 seconds. 
4. Slide washed with water, followed by alcohol, then again with water. 
5. Slide counterstained with safranin for 30 seconds. 
6. Slide washed with water, and blotted dry with filter paper. 
 
A dark purple colour indicates gram positive bacteria. 
A pale pink colour indicates gram negative bacteria. 
 
5.2.6  SEM sample preparation 
1 g of fixed sponge material was washed three times in CMF-ASW, chopped in a Virtis 
blender for 10 minutes, and filtered through 75 mm mesh to give a dissociated cell 
sample.  The filtrate was centrifuged at 1100 rpm for 5 minutes.  The resultant pellet 
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was then sequentially suspended in 50, 70, 80, 90 and 95% ethanol/water followed by 
100% ethanol for 1 hour each, centrifuging as above between each iteration.  The pellet 
was then sequentially suspended in 20, 40, 60, 80 % ethanol/amyl acetate followed by 3 
x 100% amyl acetate for 1 hour each, again centrifuging as above between each 
iteration.  The pellet was re-suspended in amyl acetate, filtered onto Whatman filter 
paper, and critical point dried with liquid CO2.  A 1 cm circle of filter paper containing 
the cells was mounted onto an aluminium stub using a carbon tab, and sputter-coated 
with ca. 40 nm gold/palladium. 
 
5.2.7  TEM sample preparation 
Dissociated cells were prepared as follows: 
1. Primary fixation:  2-3 hours in 3 % glutaraldehyde in 0.075 M PO4 buffer. 
2. Buffer wash:  3 changes of 0.075 M PO4 buffer, 10 minutes per change. 
3. Post fixation:  2-3 hours in 1 % osmium tetroxide in 0.075 M PO4 buffer. 
4. Dehydration:  10 minutes each in 20, 40, 60, 80 and 3 x 100 % acetone 
5. Infiltration:  30 % Spurr’s resin in acetone for several hours, then 75 % resin 
overnight. 
6. Embedding:  100 % Spurr’s resin, polymerised overnight at 70 °C in a beem 
capsule 
 
Ultra-thin sections (50 – 80 µm) were cut using an LKB2128 Ultramicrotome system.  
These sections were then stained with 5 % uranyl acetate for 30 minutes, washed with 
deionised water, stained with Sato’s lead stain for 20 minutes, and again washed 
thoroughly with deionised water.  They were then dried for several hours. 
 
The 0.075 M PO4 buffer, pH 7.2, was prepared by combining 36 mL of stock solution 
A, 14 mL stock solution B and 83 mL deionised water. 
 Stock solution A:  17.805 g Na2HPO4•2H2O per 500 mL (0.2 M solution) 
 Stock solution B:  15.605 g NaH2PO4•2H2O per 500 mL (0.2 M solution) 
 
5.2.8  Dissociation of sponge material 
Each sponge sample was washed three times in CMF-ASW, blended for the times 
specified, and filtered through an appropriate sized mesh.  This was repeated as 
required.  Details of each procedure are given in Chapter 2. 
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5.3 Work Described in Chapter Three 
 
5.3.1  Isolation of five new halichondrins 
One tonne of Lissodendoryx sp. was collected in 1995 in order to supply halichondrin B 
(310 mg) and isohomohalichondrin B (~300 mg) for further trials.  During the final 
purification of isohomohalichondrin B by preparative HPLC on ODS-silica 
(CH3CN/H2O, 7:3 or 9:1), twelve 2.5 L bottles of side cut residue were accumulated.  
The residue from each of these bottles was dried down individually, weighed, and 
analysed by 1H NMR and analytical HPLC on ODS-silica (CH3CN/H2O, 7:3 and 9:1) 
(SH3 10.1-12).  Signals in the 1H NMR spectra characteristic of the halichondrins (for 
example, those between 4.7 and 5 ppm corresponding to the 19=CH2 and 26=CH2 
exocyclic methylenes) were observed in the extracts of all twelve bottles.  In the HPLC 
spectra, halichondrin-like peaks, which exhibit end absorption only, were also seen. 
10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8 10.9 10.10 10.11 10.12
12 bottles of HPLC residue from isohomohalichondrin B purification:
mass (mg) 31 45.2 45.4 28.7 97.4 80.1 76.6 81.0 96.1 22.9 27.5 18.6
semi prep HPLC (55 % ACN/H2O)
SH3 20.1 - 20.23
2 fractions may contain unknown halis:
SH3 20.7 (2.1 mg)
SH3 20.11 (1.5 mg)
250 g LH20 (448 mg combined)
SH3 26.1 - 26.60 (448/60 = 7.5 mg)
SH3 26.29
SH3 26.1-26.15 26.20-26.35 26.40-50 26.55-26.60
not much materialTLC: hali material hali + other less hali + other
semi prep HPLC
30.1 30.2 30.3 30.4 30.5 30.6 30.7 30.8 30.9 30.10SH3
mass (mg) 0.5 0.4 0.7 0.6 1.4 1.1 0.8
  LP1
(3.10)
(50 % ACN/H2O)
similar to SH3 20.11 by NMR
SH3
 
Figure 5.3.1  Extraction scheme used in isolation of the five new halichondrins 
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Bottle number six was processed on a preparative HPLC ODS-silica column, eluting 
with 55% CH3CN/H2O, to give 24 fractions.  These fractions were analysed via 1H 
NMR and analytical HPLC on ODS-silica (CH3CN/H2O, 7:3 and 9:1).  Along with 
fractions containing known halichondrins, two fractions (SH3 20.7 and SH3 20.11) 
were found to contain unknown halichondrin material.  From their HPLC spectra, 
fractions SH3 20.7 (2.1 mg) and SH3 20.11 (1.5 mg) were comprised of four and two 
components respectively.  In the hope that only one component in each fraction was 
halichondrin-like and responsible for most of the mass of the sample, an attempt was 
made to separate the components of these two fractions on a 2 g LH-20 column (40 x 
0.5 cm) eluting with CH2Cl2.  However, all the components co-eluted off LH-20 in 
fractions 2 to 7, implying that they were all at the very least similar in size, if not all 
closely related halichondrins. 
In order to obtain enough of the new halichondrin material for structural 
characterisation, material from bottles three to five and seven to ten were combined 
(~300 mg), and processed on a 250 g LH-20 column (57 x 4.3 cm, eluting with CH2Cl2) 
to give 60 fractions (SH3 26.1-60).  Following DIOL TLC (4% MeOH/CH2Cl2), 
analytical HPLC on ODS-silica and 1H NMR analysis, fraction 30 (SH3 26.30, 5.1 mg) 
was selected as the starting point for further chromatographic separation. 
Fraction 30 was loaded onto a semi-preparative ODS-silica HPLC column via two 300 
mL injections, eluting with 60% and 65% CH3CN/H2O, respectively.  Peak separation 
was not sufficient in either case for collection of the individual components present, so 
all fractions were recombined.  Fraction 29 (SH3 26.29, ~7 mg) was then loaded onto 
the same column, eluting with 50% CH3CN/H2O.  Better peak separation was achieved 
using this solvent mix, and fractions 1-10 were collected (SH3 30.1-10).  From its 1H 
NMR spectrum, fraction SH3 30.6 (0.6 mg) was found to contain new halichondrin 
material.  This was similar, but not identical to, material seen in bottle number six 
fraction 11, described above.  Other fractions were found to contain known 
halichondrins.  For example, fraction SH3 30.9 (1.1 mg) was identified as the known 
53-methoxyneoisohomohalichondrin B (3.10) by 1H NMR analysis. 
Fractions SH3 20.7, SH3 20.11 and SH3 30.6 were processed by analytical HPLC on 
ODS-silica (CH3CN/H2O, 7:3) to give five pure fractions (SH3 116.2, 116.4, 118.2, 
118.3 and 118.4), which were identified as new halichondrins via analytical HPLC on 
ODS-silica (CH3CN/H2O, 7:3), 1H NMR and LCMS.  They were characterised by 
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HRLCMS and NMR.  Quantification of the samples was achieved as reported in 
Chapter 3 (Table 3.2.2).  All samples were active in the P388 assay (Table 3.2.2). 
 
5.3.2  Spectroscopic assignment of SH3 116.2 (3.13) 
White solid, estimated 50 mg sample, UV (CH3CN/H2O, 7:1) end absorption only; NMR 
data in Table 3.3.1; HRLCMS m/z 1038.5372 [M + NH4]+ (calcd for C56H80O17N, 
1038.5426). 
 
5.3.3  Spectroscopic assignment of SH3 116.4 (3.13) 
White solid, estimated 50 mg sample, UV (CH3CN/H2O, 7:1) end absorption only; NMR 
data in Table 3.4.1; HRLCMS m/z 1179.5001 [M + K]+ (calcd for C61H85O18ClK, 
1179.5062). 
 
5.3.4  Spectroscopic assignment of SH3 118.2 (3.13) 
White solid, estimated 110 mg sample, UV (CH3CN/H2O, 7:1) end absorption only; 
NMR data in Table 3.5.1; HRLCMS m/z 1099.5171 [M + Na]+ (calcd for C59H80O18Na, 
1099.5242). 
 
5.3.5  Spectroscopic assignment of SH3 118.3 (3.13) 
White solid, estimated 88 mg sample, UV (CH3CN/H2O, 7:1) end absorption only; NMR 
data in Table 3.6.1; HRLCMS m/z 1115.5530 [M + Na]+ (calcd for C60H84O18Na, 
1115.5555). 
 
5.3.6  Spectroscopic analysis of SH3 118.4 (3.13) 
White solid, 50 mg sample, UV (CH3CN/H2O, 7:1) end absorption only; NMR data up 
to C48 in Table 3.7.1.  Analysis incomplete. 
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5.4  Work Described in Chapter Four 
 
5.4.1  General experimental procedures 
The UV spectrum for compound 4.2 was measured on a Cary 300 spectrophotometer.  
The elemental analysis was carried out by Quantitative Technologies Inc. (QTI), Salem 
Industrial Park, Bldg 5, Whitehouse, NJ 08888, USA: Sample, petrobactin-SO3, %C 
40.46, %H 4.61, %N 6.86, %S 4.23. 
5.4.2  Culture and isolation 
M. hydrocarbonoclasticus (SP.17; ATCC 49840),93,94 was cultured in a hypersaline 
medium (0.5 M / 29.22 g NaCl, 0.4 g MgSO4•7H2O, 1.0 g NH4Cl, 3.0 g K2HPO4, 0.15 g 
CaCl2•2H2O and 5.0 g sodium succinate / Na2C4H4O4•6H2O per liter of Nanopure 
water) in order to optimize siderophore production.  The cultures were typically grown 
as 2 L cultures in 4 L flasks on a rotary shaker (150 r.p.m.) for 7 days.  At the time of 
harvesting, cultures were in stationary phase.  After centrifugation of the culture 
medium (5000 r.p.m., 20 min), Amberlite XAD-2 resin (Supelco) was added to the 
decanted supernatant (ca. 100 g / L), and the resultant mixture was shaken for at least 4 
hours at > 100 r.p.m..  The XAD was then loaded into a glass chromatography column 
(2 cm internal diameter), washed with one column volume of Nanopure water and 
eluted with 100 % methanol.  Using the solution-phase Chrome Azurol S (CAS) assay 
with shuttle, 103 the methanol fraction was found to contain the siderophores.  Since the 
culture medium remained CAS-positive, it was acidified to pH 2.5, re-extracted with 
XAD resin, and shaken at > 100 r.p.m. for at least 6 hours.  The XAD was again 
recovered, washed and eluted as described above.  The final purification of petrobactin 
and petrobactin sulfonate was achieved on the combined methanol fractions using 
preparative reversed-phase HPLC (Vydac C4 column (10 μm, 250 x 22 mm) using a 
CH3CN/H2O gradient (0% to 60%) over 35 minutes, with 0.1% trifluoroacetic acid).  
Acid was removed from the samples via repeated addition and evaporation of methanol 
during the drying process.  This culture and isolation work was done by Frithjof 
Küpper, a Post Doctoral research fellow in the Butler group at UCSB. 
The cyclic imides of petrobactin (4.3) and petrobactin sulfonate (4.4 and 4.5) were 
obtained by reacting petrobactin (4.1) and petrobactin sulfonate (4.2) with 0.1% TFA 
and 0.5% formic acid, respectively, in water at 40 °C for eight days.  Purification was 
by reversed-phase HPLC as described above. 
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5.4.3  Spectroscopic assignment of petrobactin (4.1) 
White solid, 12 mg sample, 1H NMR and 13C NMR reported previously,67 HRMS m/z 
719.3606 [M + H]+ (calcd for C34H51N6O11, 719.3615).68 
 
5.4.4  Spectroscopic assignment of petrobactin sulfonate (4.2) 
White solid, 10 mg sample, [a]20D –2.5° (c 0.013, DMSO); UV (DMSO) λmax (log ε) 
229 (3.95), 253 (3.83), 291 (3.74) nm; 1H NMR (DMSO-d6, 500 MHz) see Table 4.2.1; 
13C NMR (DMSO-d6, 125 MHz) see Table 4.2.1; HRESIMS m/z 799.3199 [M + H]+ 
(calcd for C34H51N6O14S, 799.3184). 
 
5.4.5  Spectroscopic assignment of petrobactin cyclic imide (4.3) 
White solid, 5.5 mg sample, 1H NMR (DMSO-d6, 500 MHz) see Table 4.4.1, 13C NMR 
(DMSO-d6, 125 MHz) see Table 4.4.1, HRESIMS m/z 701.3511 [M + H]+ (calcd for 
C34H49N6O10, 701.3510). 
 
5.4.6  Spectroscopic assignment of petrobactin sulfonate cyclic imides (4.4 and 4.5) 
White solid, 2.4 mg sample, 1H NMR (DMSO-d6, 500 MHz) see Table 4.4.2, 13C NMR 
(DMSO-d6, 75 MHz) see Table 4.4.2, HRESIMS m/z 781.3047 [M + H]+ (calcd for 
C34H49N6O13S, 781.3078). 
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